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ABSTRACT

The distribution of cell types and synapses is well characterized in the rodent
olfactory bulb (OB), and from that plausible models of odor processing have been
constructed. Individual olfactory sensory neurons (OSNs) express only 1 of ~1000
odorant receptors (ORs) and send their axons to specific synaptic targets in the OB
glomerular neuropil. Each glomerulus is innervated exclusively by OSN axons
expressing the same OR. The distribution of these glomeruli is conserved across animals,
as is the numerical relationship between number of expressed ORs and number of
glomeruli in the OB. Our objective is to extend such results to the level of the human OB
to determine how its cellular and synaptic organization, and more specifically how the
number and distribution of its glomeruli, compare to what has been elucidated in mice.
As there are ~2,000 glomeruli for ~1,000 ORs in mice, we predicted ~700 glomeruli in
humans based on the ~350 intact OR genes identified in the human through genomic
studies. Using immunohistochemistry, the organization of cells and synapses in human
OBs was evaluated and quantified. While the laminar structure of the OB is broadly
conserved between species, in the human OB the laminar organization as well as
additional structural features suggest a less rigorously organized OB than in rodents,
perhaps suggesting that odor processing in the human OB may be less efficient than in
mice. Of particular note, the total number of glomeruli in the human OB differs
significantly from predicted and demonstrates a high degree of variability amongst
specimens, thus far ranging from approximately 3000 - 9000/OB. These results indicate
that the principles of OR-homotypic axon convergence developed from mouse studies
may not be readily applicable to the human, and that central processing of odor signals in
the human may differ from those characterized in the mouse.
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INTRODUCTION

Odors are detected by a complicated chemical sensing system that is conserved
across many organisms.
Organisms use their sense of smell to detect their chemical environment, which is
a crucial function for survival. At the most fundamental level, even single-celled
organisms are able to detect and respond to chemicals in their surroundings. The ability
to smell plays a key role in higher organisms that rely on olfaction for processes such as
detecting food, staying away from poisonous substances, finding mates, and avoiding
predators. While olfaction is the primary modality in many organisms for these survival
behaviors, other organisms, such as humans, have grown to rely more heavily on their
other senses for these same behaviors.
Despite the large variation in the degree to which different organisms depend on
olfaction, the organization of this system appears to be broadly conserved across species.
Comparisons have been done between species to evaluate for similarities in several
aspects of the olfactory pathway including: receptor genes and receptor gene expression,
odorant-binding-induced signal transduction, and even certain components of central
organization and neural processing (1-3). The species examined ranged from Drosophila
melanogaster (fruit fly) in the arthropod phylum to Rana spp. (frog), Carassius aruatus
(goldfish), Mus musculus clomesticus (mouse), and Homo sapiens (human) in the
vertebrate phylum. These studies broadly demonstrated striking similarities at these
different levels of odor processing across both species and phyla. This concordance
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likely stems from a combination of homology, or inheritance from common ancestors, as
well as convergence, or adaptation to the most efficient and functional solution to
common environmental demands. There are several species in which there have been
extensive studies of the olfactory system in order to gain an understanding of odor
processing, including Drosophila, rats, and mice. Because they are mammals, most of
the assumptions about the organization of the human olfactory system are based on
rodent studies.
The unique complexity of the olfactory system is demonstrated superficially by
the relatively large number of different receptors that are used to detect odor input as
compared to the other senses that organisms use to perceive their environment. Sound is
detected by hair cells in the cochlea, which allow for pitch discrimination based on the
topography of cells activated by different frequencies of sound waves. The receptor cells
for vision are composed of rods and cones which detect light. The topography of the
cells on the retina when receptors are activated by light allow organisms to perceive
distinct images. Somatosensory detection also occurs through only a few types of
receptors; mechanoreceptors detect light pressure, nociceptors detect strong pressure, and
thermoreceptors detect heat, all providing the body with information about its physical
surroundings. Taste, the other chemical sense, is the only other sense that relies on more
than just a few different types of receptors to detect input stimuli, in this case tastants.
However, even taste receptors cannot compare in sheer number to odorant receptors; for
example mice are thought to have ~36 taste receptors (4), while they have ~1000 odorant
receptors (5-7). Because of the large numbers of inputs, mapping and understanding the
anatomic structures that integrate molecularly defined inputs at the different levels of
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odor processing is of utmost importance for learning how the olfactory system works.
Perhaps because of this organizational complexity, gaining an understanding of the
olfactory system has lagged behind other sensory systems. Major gains in this area have
occurred primarily in the last 10-15 years after the identification of the family of
receptors responsible for detecting odorants.

Odor processing begins at the level of the odorant receptors, which are represented
genetically by a large and diverse group of genes.
Mammalian odorant receptor (OR) genes comprise the largest identified family of
genes. They were first described in rats by Dr. Linda Buck and Dr. Richard Axel in 1991
(8). Buck and Axel’s original investigations were based on several novel and innovative
initial assumptions regarding the genetic, biochemical, and cellular characteristics of the
olfactory system. First, that the ORs were likely G-protein-coupled receptors, for which
there was preliminary biochemical evidence, and would therefore likely be seventransmembrane proteins. Second, they predicted that ORs would comprise a large family
of genes due to the large number and complexity of chemicals that organisms must be
able to detect and discriminate. Finally, they believed that ORs would likely be
expressed selectively in OSNs. Their assumptions proved to be correct, and their
successful discovery of OR genes earned them the Nobel Prize in Medicine and
Physiology in 2004. It also pioneered future studies that have led to an understanding of
odor processing and the organization of the olfactory system in mice and rats.
As described by Buck and Axel, ORs are G-protein-coupled receptors with a
seven-transmembrane domain. Their coding region is about 1 kb, and contains no
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introns. There are several conserved motifs that identify genes as ORs, while the
transmembrane domains 3, 4, and 5 are hypervariable, and could likely represent areas
that come together to form the odorant binding pocket (9). Signaling occurs via a Gprotein/cAMP pathway after binding of an odorant, resulting in depolarization and an
increase in spiking frequency. Interestingly, this cAMP pathway has also been shown to
play a role in axonal targeting by OSN during the wiring of the olfactory system (10).
After the discovery of the family of OR receptors in rats, work went underway to
identify these genes in other vertebrates. Most of this work used the technique of PCR
amplification with degenerate oligonucleotide primers for conserved motifs (11), work
which was facilitated by the ability to use genomic DNA instead of cDNA, as the coding
region of OR genes is intronless. Over a dozen species were selected for study (12, 13),
and confirmation of the presence of OR genes was successful in all. However, it was
unknown exactly how big this family of genes was, as these studies by no means were
exhaustive in identifying OR genes in any given species. Estimates of the complexity of
the OR family in rats ranged from 200 (8) to 500-1000 (14).
Comprehensive genomic mining studies to identify the large family of OR genes
in mice was first undertaken in 2002 after the release of the Celera mouse genome in
2000 (5, 15). These groups identified ~1300 OR genes, with only ~80% of these, or
~1000 genes, containing intact open reading frames. The remaining ~20% are
pseudogenes, containing disruptions in the coding region including insertions, deletion,
frame shifts, and premature stop codons. OR genes were found on all 20 pairs of
chromosomes in the mouse except for 12 and Y. Most OR genes occur in clusters,
defined as groups of five or more genes separated by less than 1 Mb. There are 27
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clusters in mice containing 87% of the ORs, with the remaining 13% occurring singly or
in smaller groups throughout the genome.
Due to the high degree of similarity amongst genes that are clustered together,
Zhang and Firestein (5) hypothesized that local sequence duplication was a likely
mechanism contributing to OR family expansion. They also noted that many of the OR
gene clusters contain non-OR genes. In 15 out of 27 clusters, these genes encoded
retrovirus related Gag proteins, and the density of these genes is twice as high in OR
clusters as in the rest of the genome. This data, combined with the fact that OR genes are
intronless, has led to the theory that duplication of the OR family may be retrovirusmediated (16, 17).
This sequencing of genomes from many different organisms within the last
several years has allowed for efficient mining of OR genes across multiple species. The
first draft of the human genome sequence became available in 2001 by Celera Genomics
(18) and the International Human Genome Project Consortium (19). Several groups have
used this data to fully identify the large family of human ORs. A first analysis was done
by the Weizmann Institute (20, 21), where they found 322 OR genes with intact open
reading frames. A second study was performed by the Senomyx group (22) who found
347 candidate human OR genes with intact open reading frames. While, by first analysis,
the human genome appears to have ~1000 OR genes, about 60% of these are
pseudogenes with fatal errors in their coding region. This is a much higher percentage of
pseudogenes than the 20% that has been identified both in mice (5) and rats (23), likely
representing humans’ decreased dependence on olfaction for survival over evolution
compared to other mammals.
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The average human OR is 315 amino acids long, with about a dozen conserved
sequence motifs defining these sequences as OR genes. These ~350 genes represent 1%
if the putative 30,000 genes in the human genome, as well as 1% of the 30 Mb length of
genomic DNA. They are found on all chromosomes except for chromosome 22 and the
Y chromosome. As in mice, while some genes are located singly throughout the genome,
80% are embedded within 24 larger clusters spread throughout the different
chromosomes, and 42% are found in clusters on chromosome 11.
Sequence similarities between OR clusters in humans and mice has allowed for
the identification of potentially orthologous OR gene clusters. The cluster at human
chromosome 17p13.3 and mouse chromosome 11B3-11B5 (24) shares a high degree of
homology and likely represents a common evolutionary derivative. Additional studies
have further proven the high degree of homology between human and mouse ORs (2528), representing further justification for the utilization of rodent olfaction as a model for
human olfaction. However, due to genomic changes in both humans and mice since the
rodent-primate divergence, it is impossible to identify one-to-one orthologous
relationships for most OR genes. In mice, local duplications have dominated the
differences seen between species, while in humans, deletions and interchromosomal
duplications dominate, resulting in larger OR gene clusters in mice and smaller, more
distributed clusters or single genes in humans. Young et al. (29) argues that this
represents different evolutionary forces shaping OR gene families in humans and mice,
which complicates the often accepted assumptions of common OR-ligand relationships
between these two species.
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OR proteins are expressed highly in the cilia of OSN dendrites. These cilia
project from dendrites into the mucus layer of the olfactory epithelium, located in the
posterior nasal cavity of mammals. This mucus layer is where the signal-receptor
interaction takes place between odorants dissolved in the mucus and ORs that are found
on the surface of cilia. The transcription of OR genes in these OSNs is a highly regulated
process, with any single OR gene only being expressed in a subset of OSNs.
Furthermore, single-cell RT-PCR data has shown that any given OSN only expresses a
single OR (30-32). This idea is the basis for the one receptor-one neuron hypothesis, in
which only one out of ~1000 genes in the OR family repertoire is selected for expression
in an OSN. In addition, RT-PCR looking at pools of OSNs with polymorphic OR alleles
has demonstrated that expression of ORs is monoallelic (33), a conclusion that has been
confirmed by several subsequent studies (34, 35). Both maternal and paternal alleles are
expressed in separate OSNs in approximately equal numbers.
The genetic regulation of this OR gene selection process is not well understood,
though in mouse and rats it has been shown that expression of any single OR only occurs
in one of four parallel zones in the olfactory epithelium (36-38). Within each zone,
expression of ORs appears to be completely random. While the presence of zones has
been described for over a decade, the functional role it plays in odor processing is still
unclear.

The olfactory bulb coordinates sensory input on its way to the olfactory cortex.
The OSN receives sensory input from odorants via the olfactory receptors, which
initiates a G-protein linked signaling cascade. The thin unmyelinated axons of the OSN
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then travel through foramen in the cribiform plate and carry the signal to the CNS (Figure
1A). One unique property of OSNs is that they are regenerated throughout the adult life
of all studied organisms. Therefore, even beyond the developmental stage, new OSN
axons are constantly targeting and integrating into existing central synaptic networks.
The rodent olfactory bulb (OB) is the highly organized laminar structure that receives
these OSN axonal inputs, making it the first step of odor processing in the central nervous
system. The organization of the OB is important to understanding how this level of
processing works. Interestingly, the cellular histology has been described long before the
understanding of principles of odor coding, starting with the work of Ramon y Cajal in
1911 (39). Both the cellular and synaptic structures in rodent OBs are now well
elucidated, and are reviewed in detail by Shepherd and Greer (40).
There are several categories of neurons that play a role in odor processing at the
level of the OB. These include input neurons that carry information to the OB, output
neurons that carry information out of the OB, and finally short axon intrinsic neurons that
participate in the coordination of signals within the OB. Input is received both from
OSNs that carry the actual sensory information into the OB from the nose, as well as
from regulatory centrifugal fibers consisting of axons from higher centers such as the
olfactory cortex, the anterior olfactory nucleus, the basal forebrain, and several parts of
the brainstem. Output from the OB is sent through mitral cells and tufted cells, also
known as the projection neurons. Axons from these cells leave the OB at the
posterolateral surface to form the lateral olfactory tract (LOT), which carries encoded
olfactory information to the olfactory cortex. Finally, additional regulation and
processing of olfactory signals occurs within the OB through synaptic circuits involving
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Figure 1: Overview the Olfactory System and Olfactory Bulb
The OSNs are schematically shown in A. Their cell bodies are located in the olfactory
epithelium, where they extend dendrites covered with the OR-expressing cilia into the
mucus layer. The OSN axons then travel through foramen in the cribiform plate into the
OB, where they reorganize and regroup before finding their specific synaptic targets.
The organization within the OB is based on clear laminar layers as shown through DAPI
nuclear staining in a coronal section of an adult mouse OB (B). The ONL contains the
OSN axons surrounding the OB before entering the GL to find their synaptic targets.
Next is the EPL, a cell-sparse area of dendrodendritic synapses, followed by the thin,
cell-dense MCL, which contains the cell bodies of the projection neurons, the mitral cells.
Deep to this is the IPL, and finally the GCL in the center, which contains the cell bodies
of the granule cells, a type of interneuron in the OB. Within the GCL newly generated
neurons travel through the RMS to add to and replace existing interneurons in both the
GCL and the GL. Image in A adapted from http://www.colorado.edu/epob/
epob3730rlynch/image/figure8-18.jpg. OB, olfactory bulb; OSN, olfactory sensory
neuron; OE, olfactory epithelium; RMS, rostral migratory stream; GCL, granule cell
layer; IPL, internal plexiform layer; MCL, mitral cell layer; EPL, external plexiform
layer; GL, glomerular layer; ONL, olfactory nerve layer.
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Figure 1:
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intrinsic neurons, made up of periglomerular (PG) cells and granule cells.
The layers of the OB are shown in an adult mouse OB in Figure 1B. The most
superficial layer is called the outer nerve layer (ONL), and consists of axons reorganizing
into functionally related subsets before penetrating into the OB (34, 41). Beneath the
ONL lies the glomerular layer (GL). This layer contains glomeruli, described in further
detail below, which include the distinct synaptic units between the OSNs and the
projection neurons. Below the glomerular layer is the external plexiform layer (EPL)
which contains the cell bodies of the tufted cells, as well as the dendrodendritic synapses
between projection neurons and granule cells. Next is the mitral cell layer (MCL),
containing the cell bodies of mitral cells. The internal plexiform layer (IPL) is a thin
layer between the innermost granule cell layer (GCL) and the MCL, containing output
axons from the projection neurons on their way to forming the LOT. In the middle of the
GCL, which contains the cell bodies of granule cells, is the rostral migratory stream
(RMS), through which newly generated neurons travel from the subventricular zone
(SVZ) where they are born, to their target destinations in the OB where they differentiate
into new PG cells and granule cells.
The complex synaptic circuits formed by these cells hold the key to understanding
how odor signals are processed at this level within the OB. A basic scheme of the main
synapses is depicted in Figure 2, adapted from Mori et al. (42). Within each glomerulus,
the OSN axons synapse with the primary dendrites of mitral and tufted cells. Any given
projection neuron only innervates a single glomerulus. However, these projection
neurons do send secondary dendrites laterally throughout the EPL where they form
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reciprocal dendrodendritic synapses with granule cells; the granule-to-mitral/tufted
synapse is inhibitory while the mitral/tufted-to-granule is excitatory.
In addition to the main axodendritic synapses between OSNs and projection
neurons within the glomeruli, OSNs also form excitatory axodendritic synapses with PG
cells. Also within the glomeruli are reciprocal dendrodendritic synapses between PG
cells and the mitral and tufted cells; the mitral/tufted-to-PG synapse is excitatory and the
reciprocal is inhibitory.
Within the GL but outside of the glomeruli, PG cell axons form inhibitory
synapses both with other PG cell bodies and dendrites, as well as on the primary
dendrites of projection neurons as they exit the glomeruli. It can therefore be seen that
PG cells are largely inhibitory in nature and are likely involved in negative feedback
circuits.
Collaterals from outgoing projection neuron axons on their way to the olfactory
cortex form excitatory synapses with the cell bodies of granule cells within the GCL.
The axon terminals from incoming centrifugal fibers are found in the GCL, the EPL, and
in the extra-glomerular space of the GL, therefore providing regulation of olfactory
signals from higher centers at multiple levels within the OB.

Glomeruli are anatomical structures in the olfactory bulb with topographic
specificity that play a functional role in odor processing.
Glomeruli are the spherical regions within the OB neuropil that represent the
primary synapse between OSN axons and projection neuron dendrites. In mammals,
input into each glomerulus consists of axons from thousands of OSNs (43, 44). Any one

13
Figure 2: Synaptic Organization of the Olfactory Bulb
After OSNs enter the OB, they synapse with projection neurons, the mitral cells and
tufted cells, within discrete synaptic units called glomeruli. Also participating in the
regulation of sensory input at this level are the PG cells, which form feedback circuits
within the gomeruli with both the OSNs axons and the projection neuron dendrites. The
mitral/tufted cells send only a single primary dendrite into a glomerulus, however they
send multiple secondary processes laterally that form synapses with granule cell
dendrites. The axons from the mitral and tufted cells then travel to the olfactory cortex
where the final level of odor processing takes place. White arrows represent excitatory
synapses, black arrows represent inhibitory synapses. OSN, olfactory sensory neuron;
GL, glomerular layer; PG, periglomerular cell; M, mitral cell; T, tufted cell; Gr, granule
cell. Adapted from Mori et al. (42).
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Figure 2
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OSN projects to only a single glomerulus (45). When examining the subset of OSNs
expressing the same OR in rodents, it can be seen that their axons all project to one, two,
or several distinct glomeruli (34, 46-48). The most commonly seen scenario is axons
projecting to exactly two glomeruli, one in the medial half of the OB and the other in the
lateral half of the OB. This specific targeting of glomeruli by OSN axons is made even
more complicated by the fact that the three-dimensional positions of glomeruli are
stereotyped from animal to animal within a species. Spatial mapping has been
undertaken through a variety of techniques, including 2-deoxyglucose uptake (49-51),
optical imaging with voltage sensitive dyes (52, 53), and electrophysiological recordings
from projection neurons (54). All studies in all animals have shown that identical odors
elicit characteristic spatial patterns of glomerular activity within the OB.
Very little is known about the mechanism of specific glomerular targeting by
OSN axons. In situ hybridization in rodents has demonstrated that OR proteins are
present within the OSN axons and axon terminals (46, 47). Later genetic studies were
done in mice in which deleted OR coding sequences were substituted with different
receptor sequences resulting in axon convergence to new glomerular targets (55, 56),
showing that the OR itself plays a necessary role during axonal targeting. OR guided
targeting is presently believed to occur through G protein-coupled signaling via cAMP
rather than by the direct action of OR molecules (10). However, the new glomerular
targets of these OSN axons were not exactly at the location of the substituted OR
glomeruli. This imperfect localization suggests that the ORs are necessary but not
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sufficient for exact targeting, and that the process is therefore more complex and likely
involves multiple other determinants.
In addition to the targeting specificity of OSNs to glomeruli, there is also
evidence of reciprocal specificity, in that all of the axonal inputs to a single glomerulus
are specific to OSNs expressing a single OR. Treloar et al. (57) demonstrated this in the
mouse by using electron microscopy to show that all axons synapsing within a M72
glomeruli express the M72 OR.
These results further characterize the degree of molecular specificity encoded by
the glomeruli, and additionally set up a numerical relationship between ORs and
glomeruli. If all OSNs expressing a given OR target a specific number of glomeruli in
stereotypical positions in the OB, and all glomeruli are only receiving axonal input from
one type of OR, the number of glomeruli should be directly related to the number of
expressed ORs in any given species. In mice, there are ~1000 expressed ORs, and the
number of glomeruli has been estimated at ~1800 (58). In rats, there are ~1200 expressed
ORs (23) and the number of glomeruli in the rat OB has been estimated at ~2400 (59).
There is therefore an approximate 2:1 relationship between the number of ORs and the
number of glomeruli. This confirms the previously noted observations that OSN axons
for any given OR usually project to two glomeruli - one glomerulus medially placed in
the OB and one that is laterally placed in the OB (34, 46-48); only rarely do they project
to only one or more than two (35).
This specific organization of glomeruli in the rodent OB therefore creates a
stereotyped map of ORs at this first level of central processing. It is unclear what role the
locations of each OR’s glomeruli play in the course of odor processing. However, due to
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the ability of PG cells to regulate multiple proximally located glomeruli, as well as the
ability of mitral and tufted cells that innervate separate yet adjacent glomeruli to form
dendrodentritic synapses with each other via their secondary dendrites, it is indeed likely
that the location and organization of the glomerular map has a functional role in
regulating and integrating sensory information on its way to the olfactory cortex.
Structurally similar odorants have been demonstrated to activate glomeruli in similar OB
regions, creating chemotopic maps around the surface of the OB (60-63). This, along
with the growing understanding of the synaptic circuits involving closely proximated
glomeruli, has popularized the idea that a key function of the glomerulus is to act as a
signal-to-noise enhancing device (64). Whatever the function(s) of glomeruli may be, the
preservation of their anatomic localization and molecular specificity across all studied
species is certainly striking.
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STATEMENT OF PURPOSE AND HYPOTHESIS

Qualitative evaluation of the primary organization of the human olfactory bulb.
Much work has been done to characterize the synaptic and molecular specificity
of the OB glomeruli and their development. Missing from these studies, however, is an
analysis of the human olfactory system; a determination of whether the principles of axon
convergence and molecular specificity that have been developed in rodent models extend
to the human olfactory system. Only a limited number of studies have been reported on
the organization of the human OB and these were largely carried out prior to the
development of our current molecular reagents or insights into the molecular organization
of the OB. Anecdotally, one can argue that the sense of smell in humans has degraded
over evolution, but that hypothesis has not been pursued at the level of synapse formation
or molecular specificity. Consequently, we are interested in characterizing the primary
organization of the human OB to begin to probe the widely held but untested hypothesis
that the cellular, synaptic, and molecular organization in the human OB is less precise
than that seen in other species.

Assessing the rodent-based principles of molecular specificity in glomerular maps in
the human olfactory bulb.
Rodent studies have shown that the total number of glomeruli in the OB is a direct
reflection of the number of intact ORs expressed in the olfactory epithelium; in rodents,
there are twice the number of glomeruli as there are OR genes. This leads us to the
simple though elegant method of evaluating the human olfactory system to determine just
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how similar odor processing is in these two species by counting the number of glomeruli
present in human OBs. Genomic mining in the human suggests a total of approximately
350 OR genes with intact reading frames. If the principles of axon convergence occur in
the human as they do in the rodent, we predict the human OB will have 700 glomeruli.
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METHODS

Tissue Procurement and Fixation
Human OBs were obtained through several sources including both during autopsy
from post-mortem donors as well as during neurosurgical procedures from live donors.
OBs from autopsy were kindly made available by Dr. Jung Kim from the Department of
Pathology, Yale University School of Medicine, New Haven, CT, as well as through the
National Disease Research Institute, Philadelphia, Pennsylvania. Information regarding
age, gender, and relevant medical history was obtained for all donors (Table 1).
Exclusions for this part of the study were the presence of symptomatic olfactory
dysfunction, neurodegenerative disorders such as Alzheimer’s Disease and Parkinson’s
Disease, and intranasal drug use. Procurement of this tissue and relevant donor
information passed HIC approval (#12081), and is exempt from IRB review under federal
regulation 45 CFR 46.101(b)(4). The post-mortem interval in these cases was less than
16 hours, and after procurement the OBs were fixed in 10% formalin for 7 to 28 days.
After fixation, these tissues were stripped of their meninges and washed two to three
times overnight in fresh phosphate buffered saline (PBS).
The live donor OBs were kindly obtained by Dr. Dennis Spencer of the
Department of Neurosurgery, Yale University School of Medicine, New Haven, CT,
during frontal lobe neurosurgical cases requiring disruption of the lateral olfactory tract
(HIC# 12081). OBs were obtained only in those cases in which they would otherwise be
sacrificed or discarded during the course of the surgery. These OBs were fixed in 4%
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paraformaldehyde for 24 to 48 hours. After fixation, these OBs were stripped of their
meninges and washed in PBS overnight.
For qualitative comparisons, mouse OB tissue was also obtained. Adult CD1
mice (Charles River Laboratories) were anesthetized with sodium pentobarbital (80
mg/kg i.p.; Nembutal; Abbott Laboratories, North Chicago, IL), then decapitated.
Perfusions were avoided in order to more closely replicate the conditions under which the
human OBs were obtained. The mouse brains were removed from their skulls, and their
OBs were removed and placed in 4% paraformaldehyde overnight, followed by PBS
overnight. All procedures undertaken in this study were approved by Yale University’s
Animal Use and Care Committee and follow NIH guidelines.
After fixation, all human and mouse OBs were then cryo-preserved in 30%
sucrose in PBS for 12 to 24 hours, then sectioned coronally throughout the length of the
entire OB on a sliding-freezing microtome (50µm), and stored at -20°C until use. To
maintain rostral-caudal order in the human OBs, slices were maintained individually in
48-well plates.

Immunohistochemistry
Tissue was removed from -20°C storage and washed in PBS with 0.03% Triton
100-X (PBS-T). For antigen retrieval, OB slices were steamed for 10 minutes in a
solution of 0.01M Sodium Citrate, then immediately washed with room-temperature
PBS-T. Tissue was blocked with 2% BSA in PBS-T for 45 minutes, then incubated for
48 to 72 hours in primary antibody (see Table 2 for antibodies, concentrations, and
sources) diluted in BSA-PBS-T at 4°C. Tissue was then washed in PBS-T, and incubated
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in secondary antibody (Table 2) diluted in BSA-PBS-T for 2 hours along with a nuclear
marker, DAPI (Sigma) and/or DRAQ5 (Alexis Biochemicals). The sections were then
washed in PBS-T, then PBS. In order to eliminate autofluorescence from lipofuscin
granules, sections were stained with 1% Sudan Black in 70% Methanol for 5 minutes,
then cleared in 70% Ethanol and rinsed in PBS (65). Sections were mounted with
GelMount (Bioveda).

Qualitative Characterization of the Olfactory Bulb
Antibodies as listed in Table 2 were used to characterize the organization of the
OB. MAP2 stains for dendrites, while GAP43 and NCAM are axonal markers. VGlut2
is a synaptic marker specific to OB glomeruli. To look at different classes of neurons, an
antibody against calretinin was used to identify neurons with this calcium binding
protein, GAD65/67 to identify GABAergic neurons, and TH to identify dopaminergic
neurons. Antibodies against specific mouse odorant receptors, mOR50, mOR28,
mOR256-17, and mOR267 were used to attempt to look at how axons expressing these
individual odorant receptors were organized in the human OB. All staining was done in
at least four different human OBs, and presented images are typical unless stated
otherwise.
Images were taken with the Leica confocal microscope at different magnifications
to assess the immunofluorescent results at different levels of detail. Images were also
taken of mouse OB sections stained with the same antibodies for comparison of the
distribution of cell bodies, axons, and dendrites.
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Quantifying Glomeruli
Every sixth section throughout the length of the human OBs was stained with
anti-NCAM and anti-VGlut2 primary antibodies. NCAM identifies the OSN axons,
while VGlut2 is a synaptic-associated protein that in the OB is only found at the primary
synapse between the OSN and the projection neurons, therefore defining the glomerular
unit. Glomeruli were identified by co-localization of VGlut2 and NCAM staining.
Overlapping images were taken circumferentially around each section with an
Olympus BX51 epifluorescent microscope using the 20X objective. These digitized
images were then analyzed using Metamorph software (Molecular Devices, Sunnyvale,
CA). Glomeruli were manually circled, while the software calculated total numbers of
glomeruli as well as area and length/width diameters of each glomerulus.
In this study, the length of the OB was defined by the distance encompassed by
the most rostral and most caudal OB sections that exhibited glomerular staining. The
volume was calculated by estimating the shape of the OB to be a cylinder, and the cross
sectional area was estimated by averaging the area of 4 slices distributed through the
length of the OB. The total counted glomeruli per OB was calculated by first multiplying
the total number of counted glomeruli from the sections looked at by the inverse of the
fraction of slices counted, usually around 6 as about every 6th slice was selected for
counting. Finally, to correct for the glomerular overlap between sections, the
Abercrombie extrapolation was used: N = n * (t / ( t + H )), where in this case N is the
number of glomeruli in the OB, n is the total number of counted glomeruli, t is the width
of each section (50µm) and H is the average glomerular diameter.
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Statistical analysis was performed using the Prism package (GraphPad Software
Inc., San Diego, CA). To look for relationships between the number of glomeruli and the
age of the donors, the size of their glomeruli, or the volume of their OB, a linear
regression test was performed. To look for significance between the mean number of
glomeruli in male donors versus female donors, as well as between “young” donors (<50
years old) and “elderly” donors (>50 years old), an unpaired t-test was performed. There
were no significant differences in the viariances in either of these comparisons.
All of the above mentioned procedures, calculations, and analyses were
performed by myself. Dr. Diego Rodriguez Gil, a post-doctoral associate in the Greer
lab, assisted with the statistical analyses. Instruction and guidance was provided by all
members of the Greer lab throughout my work.
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Table 1: Olfactory Bulb Donor Information
OB
Identification
HOB 1
HOB 2
HOB 6
HOB 7
HOB 15
HOB 16
HOB 20

Source Type
Surgery
Post Mortem
Post Mortem
Surgery
Post Mortem
Post Mortem
Surgery

Age of
Donor
39
89
67
66
70
85
49

Gender

Relevant Clinical Information

F
M
M
M
M
F
F

frontal lobe epilepsy
lung adenocardinoma
leukemia treated with chemotherapy
pituitary tumor
emphysema
microscopic polyangiitis
frontal lobe glioma
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Table 2: Antibodies Used for Immunohistochemistry
Antibody
MAP2
GAP43
NCAM
VGlut2
calretinin
GAD65/67
TH
mOR50
mOR28
mOR28
mOR256-17
mOR262

Animal
chicken
rabbit
mouse
rabbit
mouse
mouse
rabbit
guinea pig
rabbit
rabbit
rabbit
rabbit

Dilution
1:1000
1:1000
1:500
1:4000
1:400
1:1000
1:1000
1:3000
1:5000
1:5000
1:800
1:1500

Source
Sigma
Sigma
Sigma
Synaptic Systems
Chemicon
Stressgen
Chemicon
Dr. Richard Axel, Columbia University, New York, NY
Dr. Hitoshi Sakano, University of Tokyo, Japan
Dr. Richard Axel, Columbia University, New York, NY
Dr. Heinz Breer, University of Hohenheim, Germany
Dr. Heinz Breer, University of Hohenheim, Germany

chicken-Alexa 555
rabbit-Alexa 555
mouse-Alexa 488
guinea pig-Cy3

goat
donkey
donkey
donkey

1:1000
1:1000
1:1000
1:1000

Molecular Probes
Molecular Probes
Molecular Probes
Jackson Immunoresearch
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RESULTS

The laminar organization of the OB is broadly preserved in humans.
The rodent OB is characterized by distinct laminar structures that can be
identified using nuclear staining to evaluate the cellular distribution. As can be seen in
Figure 3A which depicts the layers of a mouse OB, the glomerular layer is clearly
recognizable by the unique distribution of PG cells outlining individual glomeruli. The
EPL is an area of sparse nuclear staining as it is the area of dendrodendritic synapses
between granule cells and projection neurons. The thin band of dense nuclei represents
the concentrated layer of mitral cell nuclei in the MCL. Finally there is another cellsparse region, the IPL, followed by the cell rich GCL. This is an extremely organized
and distinctive pattern, seen consistently in all rodents throughout the rostral-caudal
length of the OB.
Figure 3A’ demonstrates the same DRAQ5 nuclear staining of a human OB.
Clearly the layers are still present, though not as sharply demarcated as in the mouse OB.
The GL is separated by the more superficial ONL by the presence of cell-absent spots,
the glomeruli. However, unlike in the mouse OB, the PG cells do not form clearly
identifiable densities around the glomeruli, making individual glomeruli difficult to
visualize in the human GL using nuclear staining alone. Deep to the GL is the EPL,
which is seen in this image to be relatively thin compared to the mouse, while the IPL is
relatively thick compared to the mouse. However, even within human OBs, there is
actually a high degree of variability in the width of the layers.
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Figure 3: Laminar Organization of the Human Olfactory Bulb
Nuclear staining with DRAQ5 demonstrates the laminar layers of the mouse olfactory
bulb (A) and the human olfactory bulb (A’). While there is preservation of the laminar
structure between the two species, the layers are more clearly demarcated in the mouse.
In addition, the human OB demonstrates more variability in the width and organization of
these layers, which are even sometimes completely absent. Representative coronal OB
slices show the structural variations both within single slices as well as between different
OBs from different human donors (B-D). In B, there are areas of very clear laminations
(red arrow), as well as areas where the layers cannot be distinguished from each other
(green arrow). In C, the GL is completely absent around the left side, but in other areas
the laminations are very clear (red arrows). D also shows a partially circumferential GL,
and in this OB the rest of the layers seem to be completely absent as the GL ends (yellow
arrow). GCL, granule cell layer; IPL, internal plexiform layer; MCL, mitral cell layer;
EPL, external plexiform layer; GL, glomerular layer; ONL, olfactory nerve layer. Scale
bar in A is 50 µm for A, A’, scale bar in D is 500 µm for B-D.
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This variability can be seen circumferentially within one OB slice, as well as
between slices from OBs from different donors. Figure 3B-D shows examples of slices
stained with DRAQ5 from three different donors. In Figure 3B, the GL can be seen
around the entire circumference of the OB. The different layers, including the frequently
elusive MCL, are clearly demarcated through the entire depth in some areas (red arrow),
however seem to blend together deep to the GL in others (green arrow). In Figure 3C,
the GL is absent around the left side of the bulb. Despite the absence of glomeruli, there
is evidence of lamination suggesting that some level of organization persists. Again, as
in the previous image, there are points throughout the rest of the OB’s circumference
with very clear laminations (red arrow) while in other areas the laminations are less clear.
The final image (Figure 3D) shows another example of an OB with a glomerular
layer that is only partly circumferential. However, as opposed to in the previous image,
the laminations are completely absent along the top of the slice where there are no
glomeruli, and even the density usually seen around the periphery of the central GCL
disappears when the glomerular layer ends (yellow arrow). In this OB, the ONL and GL
are extremely thick compared to the other OBs pictured.

Distribution of OSN axons in glomeruli depends on axonal maturity.
The OB is a dynamic region of the central nervous system; as seen in other
species, OSNs are constantly regenerated/replaced and send their newly forming axons
through the cribiform plate into the OB, where they seek out their target glomeruli and
integrate into the dense synaptic network. To look for evidence of these newly generated
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OSN axons in the human OB, sections were co-stained with GAP43, which recognizes
immature axons in the process of finding and integrating into their target synaptic
networks, as well as NCAM, which stains all axons.
The GAP43 pattern of staining in a mouse OB demonstrates GAP43+ axons
clearly co-localizing with the NCAM+ axons in the ONL as well as glomeruli (Figure
4A). This staining pattern is also represented in the human (Figure 4B). While the
overall architecture of the OB laminations are not as precise, the distribution of GAP43+
stained axons is similar, with co-localizations seen in the ONL and glomeruli. This
image is from HOB 1, taken from a 39 year-old donor, demonstrating clearly that OSNs
are generated and replaced in adult humans. The oldest OB examined was HOB 2, taken
from an 89 year old donor (Figure 4C). In this OB as well, which qualitatively has even
poorer laminations than in the previous OB from a younger donor, GAP43+ axons are
still visualized in glomeruli, demonstrating the persistence of OSN proliferation in
humans through the entire adult life into old age.
A closer look at a glomerulus as defined by the NCAM stained OSN axons,
demonstrates the GAP43 staining around the periphery (Figure 4D). This is consistent
with observations in rodents, in which new OSN axons are integrated on the outside of an
existing glomerulus, while the more mature axons are more centrally located (66). As
additional new axons expressing the same OR arrive at their target, they in turn surround
the outside of the glomerulus, and the previous axons that are now maturing and
integrating into their synaptic networks become relatively more central.
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Figure 4: Presence and Distribution of Newly Generated Olfactory Sensory Neurons
Axons from newly generated OSNs are identified by co-localization between GAP43
(red) and NCAM (green). These axons can be seen in abundance in the ONL and
glomeruli of the mouse OB (A), showing that newly generated axons are able to integrate
into the OB synaptic network. Evidence of OSN regeneration in humans is presented in
B-D, where these axons are seen in the ONL and glomeruli similarly as in mice. The OB
slice stained in image B is from a 39 year old donor, while the OB in C is from an 89 year
old donor, indicating that OSN regeneration continues well into old-age. D is a higher
magnification showing that new OSN axons first integrate into the periphery of existing
glomeruli, a process that has been previously described in rodents. EPL, external
plexiform layer; GL, glomerular layer. Scale bar is 100 µm in A-C, and 25 µm in D.
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Glomeruli in the human OB show evidence of compartmentalization.
Previous work in rodents has demonstrated compartmentalization of glomeruli
into axonal and dendritic compartments (67-69); the axonal compartments are where the
axodendritic synapses between OSNs and projection neurons take place, while the
dendritic compartments are where the dendrodendritic synapses between the PG cells and
the mitral and tufted cells take place.
To examine whether there was evidence of compartmentalization in human
glomeruli, OB slices were co-stained with NCAM, an axonal marker, and MAP2, a
dendritic marker. Figure 5A and B show the distribution of these two markers in the
mouse and human OBs respectively. In both species, the MAP2+ dendrites are especially
prominent in the EPL, the area of dendrodendritic synapses. Dendrites are also
demonstrated extending into glomeruli in the GL, with some degree of co-localization
visible even at this low magnification between these MAP2+ dendrites and NCAM+
axons.
By examining higher magnifications of glomeruli (Figure 5C, D), the axonal and
dendritic compartmentalizations previously described only in the rodent are demonstrated
here in the human OB. The axonal areas are demarcated by the green NCAM+ staining
with some evidence of co-localization with the red MAP2+ staining, representing the
OSN-projection neuron axodendritic synapses. The dendritic areas are NCAM-, but
MAP2+, representing areas of dendrodendritic synapses as previously described. This
suggests that at the intraglomerular level, axodendritic primary afferent synapses and
local circuit dendrodendritic synapses remain segregated in the human OB and therefore
that at this level, processing of odor in the human may be similar to that described in
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Figure 5: Evidence of Glomerular Compartmentalization
In rodents, separate axonal and dendritic compartments have been defined in glomeruli,
segregating the axodendritic synapses from the local circuit dendrodendritic synapses.
The broad distribution of dendrites and OSN axons is demonstrated in a mouse OB (A)
using MAP2 (red) and NCAM (green). Nuclear staining with DRAQ5 (blue) is also seen
in A, B. As expected, the EPL is rich in MAP2+ dendritic staining, with both MAP2 and
NCAM staining seen in the glomeruli. A similar organization is seen the human OB (B)
as in the mouse. Higher magnification of glomeruli from the human OB (C,D) shows
areas specific to NCAM staining and areas specific to MAP2 staining. These represent
axonal and dendritic compartments respectively, suggesting that there is preservation of
the synaptic organization within glomeruli between rodents and humans. EPL, external
plexiform layer; GL, glomerular layer. Scale bar is 100 µm in A, B, and 10 µm in C, D.
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other species.

Periglomerular cells in the human OB do not form uniform densities around
glomeruli, however they represent a similar heterogeneous population of cells as in
rodents.
As described earlier, glomeruli in the mouse OB can be identified with nuclear
stains by their surrounding PG cells, while in the human OB, this method of identifying
glomeruli is not as clear. To further evaluate the distribution of PG cells in the human
OB, nuclear staining was combined with staining for NCAM, an axonal marker, and
VGlut2, a synaptic marker specific to glomeruli; co-localization of these two probes is a
more rigorous way of defining glomeruli, and therefore provides a way of visualizing the
relationship between PG cells and glomeruli.
The DRAQ5 staining of a mouse OB shows PG cell densities clearly demarcating
the borders of glomeruli (Figure 6A). Confirmation of these glomeruli is demonstrated
with the added NCAM and VGlut2 staining to this image, clearly showing glomeruli
within the PG cell circumferential densities (Figure 6B). However, DRAQ5 nuclear
staining from sections of a human OB are far less convincing in their ability to delineate
glomeruli through examination of PG cells (Figure 6C,E). There are areas of more
sparsely distributed cells, some of which hint at the potential locations of glomeruli,
however only rarely do the PG cells identify clear glomerular borders. When NCAM and
VGlut2 staining is added to the images (Figure 6D,F), easily identifiable glomeruli are
now able to be seen within the PG cells. This PG cell organization appears to be unique
in humans compared to mice; while in mice and other rodents the entire GL is defined by
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closely approximated glomeruli with evenly distributed PG cells consistently surrounding
every individual glomeruli, the human OB GL appears more chaotic in nature. As
described in more detail below, glomeruli in the human GL appear to be distributed
randomly, often appearing in clusters or as a lone individuals. When in a cluster, there is
a relative paucity of directly approximated PG cells relative to the central glomerular
bodies. When spaced farther apart, there are large areas of intervening PG cells that have
no physical approximation to any glomerulus; it is rare due to the compact nature of the
rodent GL to see PG cells that are not directly abutting or within close approximation to a
glomerulus. Therefore, while the GL does qualitatively appear to be rich in PG cells in
humans, there does not appear to be homogeneity in the distribution of PG cells relative
to glomeruli as there does in rodents.
PG cell populations and their chemical heterogeneity have been well described in
rodents (70). Their heterogeneity is usually defined by several substances; glutamic acid
decarboxylase (GAD), a key enzyme in the synthesis of GABA (71-74), tyrosine
hydroxylase (TH), a key enzyme in synthesizing dopamine (75, 76), and several calcium
binding proteins, including calretinin (77, 78). As PG cells are primarily inhibitory, it is
no surprise that many if not all of them contain GABA and/or dopamine, two of the
primary inhibitory neurotransmitters.
By immunohistochemical staining with antibodies for each of these distinct PG
cell markers, the relative qualitative distributions of PG cell types can be compared
between humans and mice. Figure 7A demonstrates the population of dopaminergic cells
in a mouse OB using antibodies for TH, along with NCAM to define the glomeruli. TH+
cells have large cell bodies, and are seen surrounding the glomeruli. More faintly
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Figure 6: Defining Glomeruli With NCAM and VGlut2 Co-Localization
Due to the well organized compact nature of glomeruli within the GL in the mouse OB, it
is easy to define glomerular borders based on the presence of surrounding PG cell
densities using DRAQ5 nuclear staining (A). The locations of these glomeruli are
confirmed by the addition of NCAM (green) and VGlut 2 (red) to the DRAQ5 staining
(blue) (B) of the same image. However, in the human OB, the glomeruli are not
regularly and compactly organized, and the PG cells do not form clear circumferential
densities around their borders, making identification with DRAQ5 staining alone difficult
(C,E). However, the addition of NCAM and VGlut2 in these same images is able to
define the locations of these glomeruli clearly (D,F). In addition to highlighting the
degree of variability in the size, shape, and distribution of the glomeruli, this also allows
for the better characterization of the relationship between glomeruli and surrounding PG
cells, which is also demonstrated to be more variable than compared to mice. EPL,
external plexiform layer; GL, glomerular layer. Scale bar in F is 50 µm for A-F.
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staining processes can be visualized extending into the glomeruli, representing the PG
cell axons that synapse with the dendrites of projection neurons as well as occasionally
with the axons of the OSNs. Though not pictured, rare TH+ cells can also be seen in the
deeper layers in the mouse OB.
Figure 7B shows TH staining in the human at low magnification. Again, cell
bodies are seen in the GL. While many are closely approximating glomeruli, some are
more isolated within the GL. This image also depicts several TH+ cell bodies within the
GCL. By observation, the percentage of cells in the GL that are TH+ appears to be
lower than in the mouse. At higher magnification (Figure 7C) the large-bodied TH+ cells
are seen surrounding the glomerulus, with processes extending into the glomerulus; areas
of co-localization are present between these TH+ processes and NCAM+ OSN axons.
Calretinin+ PG cells can be seen in the mouse OB surrounding glomeruli defined
by VGlut2 staining (Figure 7D). These cells are more abundant than the dopaminergic
cells, and have smaller cell bodies. Calretinin+ cells are also found with relatively high
frequency in the deeper layers of the OB. Calretinin stains processes very strongly, and
even at this low magnification, calretinin+ staining can be seen within the glomeruli.
In the human, the calretinin+ PG cells are also more frequent than dopaminergic
PG cells (Figure 7E). These cells seem to be more closely approximated with glomeruli
than TH+ cells, only rare calretinin+ cells are seen in the GL that are not directly
approximated with a glomerulus. Again, the strongly staining processes are seen in the
glomeruli, even at the low magnification the co-localization between VGlut2 and
calretinin can be seen. This is better pictured in the higher magnification image (Figure
7F). As in the mouse, these calretinin+ cells have smaller cell bodies and are seen in
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Figure 7: Molecular Phenotypes and Distributions of Periglomerular Cells
Large-bodied TH+ (red) cells are seen surrounding glomeruli, as defined by NCAM
(green), in the mouse OB (A). A similar distribution is seen in the human OB (B). A
closer look at a single glomerulus in the human OB (C) demonstrates the large-bodied
TH+ cells surrounding and sending processes into the glomerulus. Calretinin+ (green)
cells have smaller cell bodies, and are seen in a mouse OB even more abundantly staining
PG cells around glomeruli, in this case identified with VGlut2 (red) (D). A similar
distribution is seen in the human OB, with many calretinin+ PG cells surrounding the
unevenly distributed glomeruli, into which they are extending many darkly stained
processes. This is seen in greater detail in F, which also demonstrates more clearly the
smaller cell bodies of calretinin+ cells. The GAD65/67 antibody stains processes very
darkly, and the EPL is dense with these GAD65/67+ (green) processes in the mouse OB
(G), however abundant GAD65/67 cell bodies can be seen surrounding the VGlut2+ (red)
glomeruli. The EPL is similarly dense with processes in the human OB (H), and
processes can also be seen around the glomeruli in the GL. At a higher magnification in
the GL of a human OB (I), fewer cell bodies are obviously GAD65/67+ as compared to
in the mouse, some of the more clearly stained cells are identified with arrows. However,
this is likely due to the poor staining quality of the antibody, in fact most PG cells have
some degree of co-localization with GAD65/67. The quantities and distributions of these
classes of cells are therefore seen to be similar in mice and humans, suggesting
similarities between local processing of olfactory signals at this level. DRAQ5 staining
of nuclei is blue in all images. EPL, external plexiform layer; GL, glomerular layer.
Scale bars are 50 µm in A, D, G, 100 µm in B, E, H, and 25 µm in C, F, I.
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fairly high density.
GABAergic cells are characterized by staining with an antibody against
GAD65/GAD67. Glomeruli were defined with VGlut2. This antibody has relatively
poor staining of cell bodies while staining of the processes is very strong. A large
amount of staining of these processes is seen in the EPL of the mouse OB, with cell
bodies pictured very densely packed around glomeruli in the GL (Figure 7G). These
cells have medium-sized cell bodies, and are the most abundant of the PG cells, which is
consistent with the finding is this image.
In the human OB, GAD65/67+ staining is particularly prominent in the EPL as
well (Figure 7H). Less densely stained processes can be seen around the glomeruli,
however no distinct cell bodies can be identified at this low magnification. At higher
magnification, several VGlut2+ glomeruli can be seen surrounded by GAD65/67+ cells
(Figure 7I). Due to the poor cell body staining, GABAergic cells are difficult to clearly
identify; several of the more prominently stained cells are labeled with an arrow.
However, upon close examination, many of the DRAQ5 stained nuclei surrounding these
glomeruli demonstrate small but visible co-localization with GAD65/67. This, combined
with the clearly identified GAD65/67+ processes surrounding and innervating the
glomeruli confirms the localization of GABAergic PG cells in the GL. Unfortunately the
staining quality prohibits further speculation about the relative quantities of these cells as
compared to rodents.
In summary, all three types of PG cells, including dopaminergic cells,
GABAergic cells, and cells expressing calcium binding proteins, are present in the GL of
humans. They appear to be present in the same relative quantifications as in mice, with

45
the exception of the GABAergic cells in which no conclusions could be made due to
limitations in the immunohistochemical staining in the human OB. Finally, all three
types of cells appear to be distributed in the OB similarly as in mice, and most notably in
the GL they are all closely surrounding the glomeruli. While not conclusive, these
histological descriptions are consistent with the idea that the same types of synaptic
circuits between OSNs, mitral/tufted cells, and PG cells are also present in the human and
may play a role in the initial processing of sensory input into the OB. One important
observation, however, is that in the GL in the human OB there does not appear to be
homogeneity in the distribution of PG cells relative to glomeruli as there does in rodents,
and there are large areas within the GL without glomeruli that are still dense with PG
cells. Interestingly, while the PG cells directly surrounding glomeruli in the human were
stained consistently with the TH, GAD65/67, and calretinin antibodies, only rare PG cells
in these intervening areas were stained. It is unclear what the nature of the cells in these
areas are or how they may contribute to the synaptic organization in this layer.

The distribution of glomeruli in the OB is not preserved between specimens.
Rodents have very specific odor maps, with stereotyped locations of glomeruli for
each specific OR that are conserved from animal to animal. For each OR, there are
usually two, though sometimes one or a few, glomerular targets, one located on the
medial wall of the OB and the second located on the lateral wall. These precise odor
maps in mice are composed of regularly-spaced glomeruli evenly distributed almost twodimensionally in a sheet around the surface of the OB.
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To broadly look at the general distribution of glomeruli in the human OB, slices
were co-stained with NCAM and VGlut2. By looking at representative low
magnification slices arranged rostrally to caudally throughout the length of one of the
OB’s, HOB1 (Figure 8), it can be seen that the distribution of glomeruli around the OB is
very different in humans than in mice. While in mice they are regularly spaced in a thin,
circumferential layer, in the human OB glomeruli are often clustered in groups. In the
images presented, these clusters are represented by thick NCAM+ axon densities that
branch out into large groups of VGlut2+ glomeruli that are often overlapping and that
extend the width of the GL deeper into the OB. There are several of these clusters that
can be seen throughout the representative slices. They are in different areas of the
circumference, though the overall distribution of glomeruli in this OB is lateralized to
about half of the overall circumference. This localization remains consistent throughout
the entire length of the OB until it tapers off at the most caudal end. Outside of the
clusters, the other areas along the circumference seem to have a more uniform thickness,
however even here the distribution of glomeruli is not evenly spaced as they are often
clumped together or completely absent.
This non-circumferential distribution was seen in all OBs examined, however the
extent to which the glomeruli were limited to one area was variable from specimen to
specimen, as was the particular area to which they were localized. Representative low
magnification slices from several different human OBs, taken from mid-OB except where
noted, demonstrate the variety in the distribution around the OB (Figure 9). HOB 20
(Figure 9A) and HOB 6 (Figure 9B) have a similar type of lateralization as was seen in
HOB 1 (Figure 8). However HOB 20 has a thick NCAM+ ONL and glomerular layer as
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Figure 8: Limited Circumferential Localization of Glomeruli
The localization of glomeruli around the circumference of a single OB, HOB 1, through
its rostral-caudal length is shown starting rostrally in A and ending caudally in H.
Glomeruli are identified by co-localization of NCAM (green) and VGlut2 (red). Nuclear
staining is with DAPI (blue). Clusters of glomeruli can be seen in the GL with
intervening areas that are more sparse in glomerular density, unlike the mouse OB in
which the glomeruli are regularly spaced, and usually only 1-2 glomeruli thick. The
thickness of the GL shown here is variable amongst slices, but the non-circumferential
lateralization of glomeruli remains consistent throughout the entire length. Scale bar in H
is 500 µm for A-H.
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in HOB 1, while HOB 6 has a very thin ONL and sparse glomeruli. In several of the
OBs including HOB 20, the glomeruli could be seen completely circumferentially in the
most rostral slices (Figure 9C) until becoming more localized in their distribution. HOB
15 had a particularly large distribution, almost completely circumferential (Figure 9D).
HOB 7 and HOB 2 had distributions that each covered about half of the circumference,
however, each was distinctive in their localization; in HOB 7 glomeruli were lateralized
side-to-side, while in HOB 2 they were lateralized up-to-down (Figure 9E,F). These
images highlight the broad spectrum of variations in the glomerular pattern, both in the
amount or the circumference surrounded by glomeruli as well as in the localization
within the circumference. This variability demonstrates that, as opposed to in rodents, it
is unlikely that humans have a stereotypical spatial targeting within the OB for axons
expressing specific ORs that is identical amongst all members of the species.
To try to explore this further and examine the localization of specific OR
glomeruli, slices throughout the OB were stained immunohistochemically with probes for
several ORs (see Table 2). These included antibodies targeting mOR50 (Mori), mOR28
(Sakano), mOR28 (Axel), mOR256-17 (Breer), and mOR262 (Breer). ORs are expressed
in the axons of OSNs, so successful staining should demonstrate OR+ axons surrounding
the OB in the ONL, as well as OR+ glomeruli representing the glomerular targets for the
specific OR. Although these antibodies were developed against mouse ORs, it was
hoped that they might recognize human ORs as well, since as previously discussed, there
is a high though variable degree of sequence homology between OR genes from the two
species. By seeing OR+ glomeruli, this study might be able to confirm molecular
specificity of glomerular inputs in the human. In addition, it would describe the

50
Figure 9: Variability in Glomerular Localizations
The broad range in glomerular distributions is shown in OBs from several different
donors. Glomeruli are identified by co-localization between NCAM (green) and VGlut2
(red), nuclear staining is with DAPI (blue). The most rostral tip of several of the OBs,
such as HOB 20, exhibited glomeruli around the entire circumference of the OB (C), after
which they usually became far more localized. Other than C, all images in this figure are
taken from slices that are mid-OB. The most common localization is shown in HOB 20
and HOB 6 (A,B), however the laminar organization is very different between these two
OBs, with HOB 20 having a very thick GL and dense glomeruli, and HOB 6 having a
very thin GL and sparse glomeruli. In HOB 15 (D), glomeruli are seen surrounding
almost the entire OB, with some glomeruli extending out of the GL deeper into the bulb.
In HOB 7 and HOB 2 (E,F) glomeruli are seen surrounding about half of the
circumference, however in HOB 7 the lateralization is side-to side while in HOB 2 the
lateralization is top-to-bottom. While rodents have a very stereotypical odor map that is
preserved from animal to animal, because of the broad ranges in the distributions of
glomeruli around the OB, it is unlikely that this is the case in humans. Scale bar in H is
500 µm for A-F.

51
Figure 9:

52
Figure 10: Single Odorant Receptor Expression in the Olfactory Nerve Layer
In order to examine the distribution of single-OR axons and glomeruli, human OB slices
were stained with a mix of antibodies developed against individual mouse ORs, which
included mOR50 (Mori), mOR28 (Sakano), mOR28 (Axel), mOR257-17 (Breer), and
mOR262 (Breer). Due to the high degree of homology between human and mouse OR
sequences, it was hoped that these antibodies would recognize human ORs as well.
Evidence of positively stained axons with characteristic knobby densities are present in
ONL (A,B), however no glomeruli were visualized. ONL, olfactory nerve layer. Scale
bars are 10 µm.
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distribution of specific OR glomeruli in the bulb, and might be able to provide further
insight into the numbers of glomeruli targeted by OSN axons for each OR.
Unfortunately, while there was no conclusive evidence of OR+ glomerular
staining, there was suggestive OR+ staining in the ONL (Figure 10A,B), which implies
that the OR antibodies developed against mouse sequences are able to cross-react with
humans. However, due to the lack of identified glomerular staining, no further insight
was provided regarding homotypic axon convergence or molecular specificity of the
glomeruli.

Humans have many more glomeruli than models of olfactory processing established
in rodent models would predict.
In rodent models, the total number of glomeruli in the olfactory bulb is a direct
reflection of the number of intact ORs expressed in the olfactory epithelium. In both rats
and mice, there are twice as many glomeruli as there are OR genes. By evaluating the
number of glomeruli in humans, it can be determined whether principles of axon
convergence occur in the human as they do in the rodent. We used co-localization of
NCAM and VGlut2 to define glomeruli. In addition to counting the glomeruli from
representative slices throughout each OB, each glomerulus was circled to measure its
two-way diameter and area.
Table 3 shows the final results of this study for the seven OBs that were
examined. The average number of glomeruli was 5568 ± 830 (mean ± S.E.M.), many
times more than the 700 predicted based on the estimated 350 intact OR genes in humans.
In addition, as demonstrated by the large standard error, there was a huge range; the
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smallest number counted was 2975 from HOB 6, and the highest 9325 from HOB 20.
While based on a small n, these huge counts are many times higher that predicted, and
seem to clearly disprove the hypothesis that there would be about 700 glomeruli. This
implies that through evolution, in the time since primate-rodent divergence, humans have
developed different principles of axon convergence and glomerular targeting, which in
turn may reflect a variation in the way odor is processed at this level.
The glomerular diameters were calculated based on two-way measurements
across the circled glomeruli, with an average diameter of 59.6 ± 1.4 µm. However, this
standard error represents the range of glomerular diameters averaged from each of the
OBs. In fact the actual range of diameters was much larger than this, with the smallest
measured glomerulus having a diameter of 15.8 µm and the largest measured glomerulus
having a diameter of 185 µm. In addition to this huge variation in size, these human OB
glomeruli exhibited extreme variations in shape, with often the two axis measurements
being extremely disparate for a given glomerulus. However, the two diameters defining
the individual glomerular shapes averaged out to within only a few microns for each of
the OBs. This indicates that the average two-dimensional shape of glomeruli in the
human is circular despite the huge variability between individual glomeruli, and therefore
the average structural shape is spherical.
The average length of the OBs, defined by the rostral-caudal distance between the
first and last coronal slices that contained glomeruli, was 9.52 ± 0.49 mm. The mean area
of the coronal cross-section of the OBs was 5.52 ± 0.32 mm2, and was seen within an
individual OB to remain fairly consistent throughout the length except at the most rostral
tip, suggesting that the three-dimensional shape of the human OB is more like a cylinder
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Table 3: Olfactory Bulb Analysis Data
ID

OB Length
(mm)

Average Area
of Slice (mm2)

HOB 1
HOB 2
HOB 6
HOB 7
HOB 15
HOB 16
HOB 20
Mean ± S.E.M.

7.05
9.60
9.50
11.35
9.40
9.35
10.40
9.52 ± 0.49

4.30
5.99
5.73
4.39
6.28
5.64
6.28
5.52 ± 0.32

Total OB
Volume
(mm3)
30.32
57.50
54.44
49.83
59.03
52.73
65.31
52.74 ± 4.19

Average
Glomerular
Diameter (µm)
65.13
55.15
56.17
59.29
57.44
62.68
61.37
59.60 ± 1.41

Total
Glomeruli
(corrected)
4595
4184
2975
6530
7150
4221
9325
5568 ± 830
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than like an elliptoid. Using this assumption of a cylindrical shape, the mean volume of
the OB was calculated to be 52.74 ± 4.19 mm3. Previous MRI imaging has measured the
volume of OBs from patients with normal olfaction to be from 59 mm3 to 119 mm3 (79).
While this is a bit higher than the volumes seen in our study, this likely reflects the fact
that we used a functional definition of volume based on the presence of glomeruli, which
is a clear way of identifying the transition between OB and LOT, and which was seen to
occur before the anatomic narrowing of OB to LOT was clearly visible.

There is no relationship between number of glomeruli in human OBs and either age,
gender, or OB size.
There was a huge range in the number of glomeruli counted from these seven
human OBs. To look for possible associated factors, the relationship between the number
of glomeruli and the age of the donor, the gender of the donor, the average diameter of
the glomeruli, and the size of his/her OB was examined. A previous study described an
inverse relationship between age and number of glomeruli (80); however, we did not find
a correlation between the two variables as measured with a linear regression test (p=0.39)
(Figure 11A). When placed in two age categories of “young” (age less than 50 years old)
and “elderly” (age greater than 50 years old), the average number of glomeruli in OBs
from the the “young” group was 6960 ± 2365 (n=2), while in the “elderly” group it was
5012 ± 785 (n=5) (Figure 11B). While there are fewer glomeruli in OBs from the
“elderly” group, using an unpaired t-test this difference was not found to be significant
(p=0.33). These findings are different from those of Meisami’s group, and possible
explanations for these discordant conclusions are described in more detail below.
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In addition, the data was grouped by gender, with the average number of
glomeruli in OBs from female donors calculated as 6047 ± 1643 (n=3), and from male
donors, 5210 ± 981 (n=4) (Figure 11C). There is no statistical significance between these
groups either (p=0.66). Finally, there was no correlation between glomerular number and
average glomerular size (p=0.71) (Figure 11D), or between glomerular number and OB
volume (p=0.31) (Figure 11E).
Based on the small n of 7, there is not a large amount of data to support the power
of these comparisons. Nevertheless, the only relationships that begin to even support a
trend are between number of glomeruli and OB volume, as well as number of glomeruli
and age. Only by increasing the number of human OB samples can it be seen whether
true relationships develop in these cases. However, it is most likely that the main
sources of variation in the number of glomeruli between different individuals lie outside
the parameters measured here.
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Figure 11: Relationships Between Total Glomeruli and Age, Gender, Glomerular
Diameter, and Olfactory Bulb Volume
No significant relationship were found between total glomeruli and donor age (p=0.39)
(A). There was a trend towards decreasing numbers of glomeruli with increasing age,
however even when split into two groups of “young” (age less than 50 years old) and
“elderly” (age greater than 50 years old), the difference was not significant (p=0.33). The
average number of glomeruli in OBs from the “young” group was 6960 ± 2365 (n=2),
while in the “elderly” group it was 5012 ± 785 (n=5) (B). When grouped by gender, the
mean number of glomeruli in OBs from female donors was 6047 ± 1643 (n=3), and from
male donors, 5210 ± 981 (n=4), which was also not significant (p=0.66) (C). Finally,
there was no correlation between glomerular number and average glomerular size
(p=0.71) (D), or between glomerular number and OB volume (p=0.31) (E). Linear
regression tests were performed to look for significance in A, D, E. Unpaired t-tests were
performed for the two-group comparisons in B, C. There were no significant differences
in variance for either of these comparisons.
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DISCUSSION

The organization of the human OB is preserved, but is less precise than in rodents.
Previous work to describe the human OB histologically was largely undertaken
before the availability of our current molecular reagents or insights into the molecular
organization of the olfactory bulb. Early immunohistochemical analyses were able to
define the presence of synapses and several classes of PG cells, such as those examined
here, within the human OB (81-86), but at the time there was very little understanding of
the intricate neuronal circuits involved in the OB. In fact, most of these studies were
performed before the odorant receptor had even been identified by Buck and Axel in
1991 (8), the discovery that pioneered the understanding of molecular specificity and
glomerular odor maps.
Much of the recent work done with the human OB tissue is related to clinical
interests in how different diseases, especially neurodegenerative diseases, manifest in the
OB. These studies, summarized below, provide little insight into the actual organization
of the human OB that is relevant for understanding how it compares to that of the rodent
models in which the principles of odor processing were first discovered. Therefore, this
current work, while by no means comprehensive, is novel in providing an initial look at
the organization of the human OB with regard to these important principles.
The qualitative evaluation of the human OB presented here evaluates several
components of OB organization, including the preservation of laminar layers, the
presence and distribution of new OSN axons, the compartmentalization of glomeruli, the
organization and molecular identity of PG cells in the GL, and finally the distribution of
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glomeruli around the OB. Because so much that is now understood about odor
processing in rodents has a defined anatomical basis, such anatomical studies of the
human OB can provide insight into similarities and differences between odor processing
in these two species. Based on these analyses, there are several lines of evidence that
support the preservation of OB organization in humans, while several others highlight
potential differences between the two.
Definitive evidence is presented here that, as in rodents, OSNs are regenerated
throughout the entire adult life of humans, and that these new axons integrate into
established glomeruli in a manner typical to what is seen in rodents. This dynamic nature
of the sensory input requires the coordination of factors related to axon growth, guidance,
and integration within synaptic networks in order to maintain the complex organization
within the OB. Any failures in these processes that detract from OB organization may
have functional consequences in the efficiency and accuracy of odor processing. While
not evaluated here, there is preliminary evidence that in humans, as in rodents, new PG
cells and granule cells are also regenerated (87). If true, this would add additional
complexity to the dynamic nature of the organization of the human OB.
Olfactory function is known to decline steadily after the age of 40 (88), with a
prevalence of olfactory dysfunction in elderly people as high as 70% (89). This occurs
despite the ability to regenerate OSNs. Therefore, a potential explanation for this age
related decline in olfactory function is in fact an accumulation of organizational errors
due to inaccuracies in axon targeting and synaptic integration of these newly generated
neurons over time. Due to the complicated integration of sensory information between
cells from all layers including PG cells in the GL, mitral and tufted cells, and granule
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cells from the GCL, such errors might have organizational consequences throughout the
entire OB. In possible support of this hypothesis, there appeared to be qualitative
differences between the OBs from younger donors compared to older donors, with older
donors demonstrating strikingly less clear laminations in the OB structures. Contributing
to this apparent decline in the clear demarcations between cell types and synapses is the
presence of glomerular structures that extend beyond the GL into the EPL, observations
that were also noted indirectly by several groups of clinician investigators (90, 91).
Therefore, while laminar organization is a concept that is preserved in the human OB,
because it is such a dynamic structure, perhaps over the long duration of the lifetime of a
human inaccuracies accumulate that have anatomic and functional consequences.
At the level of the glomerulus, there were several observations in this study that
suggest that the local synaptic regulation of incoming sensory signals is preserved in
humans. The PG cells have molecularly defined identities that are similar to that
described in rodents with similar distributions surrounding the glomeruli. Additionally,
glomeruli have segregated axonal and dendritic compartments that represent,
respectively, the axodendritic synapses between OSNs and mitral/tufted cells, and
dendrodendritic synapses involved in local PG cell circuits. Despite these important and
revealing similarities, there are general organizational differences in the GL between the
two species that bear discussion. While the GL in mice is composed entirely of glomeruli
with surrounding PG cell densities, as seen in this study, the GL in human OBs contains
clusters of glomeruli without the surrounding PG cell densities that are seen in mice, as
well as areas of PG cells that have no glomeruli.

64
The clusters of glomeruli with a relative paucity of surrounding PG cells may be
another example of changes in the structural organization of the human OB that may have
functional consequences and contribute to the evidence that humans have a weaker sense
of smell. PG cells play an important role in local feedback circuits in the GL that may
serve to increase the sensory signal as well as potentially inhibit signals from areas of
input represent similar but different odors. Therefore, efficiency at this level may be
reflected in low odor detection thresholds as well as the ability to discriminate between
different odors. Accordingly, having low as well as variable ratios of PG cells to
glomeruli, it can be seen that there may be functional consequences in these measures of
olfaction.
However, perhaps glomeruli do not necessarily need to be abutting the PG cells
with which they form synapses. There are many areas dense in PG cells without
proximal glomeruli. PG cells are able to extend long processes, as seen in the TH,
calretinin, and GAD65/67 staining presented in this study. Therefore, even without the
physical proximity it is possible that these PG cells are involved in local circuits from a
greater distance, and the density of PG cells seen surrounding glomeruli in mice is simply
to maximize the efficiency of a limited GL space, rather than because it has any
functional necessity. However, an argument against this hypothesis is that very few of
the many PG cells that were not directly surrounding glomeruli in the human OB were
actually labeled with any of the PG marker probes, which are also indications of
functionality. In mice, over 80% of PG cells are labeled with any one or more of these
probes (70). Perhaps PG cells in the human are participatory but preferentially belong to
a category of cells not identified by these markers. Or contrary, these are non-functional
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cells that are either remnants of earlier synaptic circuits that no longer exist, or else they
could be newer generated PG cells that never found a target synaptic circuit in which to
integrate. While the role of these cells is unclear, they are potentially another source of
evidence of deviation from the organization of the OB as defined in rodents.

Large numbers of glomeruli in the human OB suggest a difference in the way that
OSN axons find their glomerular targets as compared to rodents.
One of the most important principles of odor processing in the OB that has been
well established in rodents is the idea of molecular specificity; that OSN axons entering
the OB form homotypic axon bundles within the ONL with other axons from OSNs
expressing identical ORs before penetrating into the OB into their target glomerulus.
This is a fundamental principal that identifies glomeruli as functional units and allows for
efficient modulation of sensory input at this very first level of odor processing. However,
this molecular specificity has not yet been confirmed in the human OB. One simple way
to begin to address this is to see whether the numerical relationship between ORs and
glomeruli that the principle of molecular specificity establishes is maintained in humans.
Based on rodent models, it was predicted that the human OB would contain ~700
glomeruli, twice the ~350 OR genes that have been predicted based on genomic mining
studies. However, counting the glomeruli from seven OBs demonstrated the actual
number of glomeruli to range from 2975 to 9325, with an average of 5569. By defining
glomeruli by co-localization with NCAM and VGlut2, a synaptic marker that is specific
to glomeruli, this study was able to more rigorously delineate glomeruli for counting and
measuring than a previous study done by Meisami et al. that attempted to look at numbers
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of glomeruli in the human OB (80). This group looked at Nissl staining, and therefore
relied on the PG cells to outline glomeruli. As demonstrated here, PG cells are rarely
arranged in circumferential densities around regularly sized and shaped glomeruli, which
are often clustered together. While the Meisami group found about 8000 glomeruli in
young people, which falls within the range identified in this study, they also found a
linear decline in glomeruli with age, with only about 2000 glomeruli in the oldest group.
While we did not see any clear indication that there was a correlation between age and
number of glomeruli, we did see qualitative differences between the OBs from older
donors compared to younger donors, with more poorly defined laminar layers and larger
variability in the shapes and distributions of glomeruli. Therefore, the fewer number of
glomeruli counted by Meisami et al. in this older group is likely a consequence of the
decreased organization in the GL, making identification of glomeruli based on PG cells
even more difficult.
Using a synaptic marker that is specific to glomeruli, VGlut2, is an unequivocal
method of identification. However, there were still many difficulties encountered during
the counting process. As can be seen from the images of the human (Figure 8), glomeruli
are clustered together, often overlapping within one 50 µm slice. This difficulty was
made particularly complicated by the fact that glomeruli in human often have atypical
shapes, unlike the almost universal spherical shape seen in rodents. Therefore, with
overlapping glomeruli with unusual shapes, it was often hard to define exact borders or to
distinguish closely approximated glomeruli from one another. In addition, the
compartmentalization within glomeruli established earlier (Figure 5) is also seen with
VGlut2 staining, and was sometimes very prominent. This made distinguishing
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prominent compartmentalizations within a single glomerulus from multiple smaller
clustered glomeruli more difficult. Finally, using the Abercrombie extrapolation might
have also introduced some small error into the final calculation. This formula corrects
for the idea that three-dimensional objects are often split between slices and would
therefore be double-counted. The calculation makes the assumption that the objects
counted are spherical, which is demonstrated here to not be the case. However, despite
the variability amongst individual glomeruli that was encountered, the two dimensional
diameter measurements did average out to very close to a circle in every OB. Lastly,
glomeruli were only counted in a total of seven human olfactory bulbs. This is a very
small n, and it is likely that the final numbers of glomeruli are not perfectly representative
of the population; despite this, the entire range varies significantly from the predicted
value, making it extremely unlikely for the principles of axon convergence and OB
organization that have been defined in rodents to be identical in humans.
Despite these minor difficulties, this was an extremely rigorous evaluation of the
number of glomeruli with truly unexpected results. Why are there so many glomeruli in
the human? Does this deviation in organization also imply that there has been a loss of
molecular specificity within the human OB? Not necessarily. Perhaps in humans the
anatomically based definition of a glomerulus is different, and there has been a
fragmentation of the prototypical spherical glomeruli into smaller units. The average
glomerular size in humans is ~60 µm, smaller than the 85-100 µm in mice, despite having
a larger OB. Perhaps as the size of the glomerulus becomes larger with accumulating
axonal inputs, there is a decrease in efficiency of regulation with the surrounding
periglomerular cells, resulting in a fragmentation of the glomerulus into smaller units.
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The occurrence of sometimes discrete clusters of glomeruli in humans is something that
is not seen in rodents, where the glomeruli are almost linearly arranged around the OB.
So perhaps what is a discrete sphere in a mouse, is, in humans, a cluster of glomerular
units representing a single OR. In this way, not only would there be preservation of
homotypic convergence, but there could still be the numerically retained relationship
between ORs and glomerular target areas, if there were about 700 of these clusters in the
OB. However, even if this were the case, the high variability in circumferential
glomerular localization (Figure 9) makes the idea of odor maps that are conserved
between individuals extremely unlikely.
Another hypothesis addressing these high glomerular counts in which molecular
specificity and organization is maintained is related to the potential emergence of
frequent polymorphisms within human olfactory receptor genes. Linardopoulou et al.
(92) identified up to 5 amino acid differences in copies of the same OR gene from
different individuals. Therefore, because of the unique property of OR gene expression
in which only one allele is expressed in any given OSN, polymorphisms in one allele of a
certain OR would lead to two distinct cell populations within the group of OSNs that
express that OR. It has been additionally discovered that even small changes to the
amino acid sequence of an OR can affect the targeting of axons to their glomerulus (93).
Taken together, this evidence indicates that there may be distinct glomeruli representing
two different versions of a single OR gene. While the presence of polymorphisms alone
is unlikely to account for the large numbers of glomeruli seen in human OBs if all other
principles of axon targeting are upheld, this presents an interesting point that certainly
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adds complexity to the human olfactory system and would indeed account for larger
numbers of glomeruli than predicted.
Another potential explanation for the large number of glomeruli is that instead of
each OSN axon that expresses any given OR targeting one of two possible glomeruli in
the OB, there are many more potential glomerular targets. In this hypothesis, while there
is maintenance of molecular specificity in which all axons converging on a single
glomerulus express the same OR, there is a loss in the organizational efficiency seen in
rodent OBs. For 350 human ORs, with about 5500 glomeruli, that would mean that there
would be an average of 16 potential glomerular targets per OR. Part of the elegance of
the rodent model is that having only two glomeruli per OR efficiently organizes olfactory
input in the central nervous system immediately at the first stage of processing.
Therefore, by having so many glomeruli per OB, it can be perceived as a loss in
efficiency at this level. As glomeruli are considered functional units in the process of
integrating sensory input, such a dispersion of input units would require compensation
through more complex local organization in the PG cells and granule cells, or at higher
levels in the cortex. If this compensation does not occur in this model, it is possible that
such a loss in OB odor map organization may play a role in the human’s relatively poor
olfactory sense.
The final potential explanation for such a large number of glomeruli in the human
OB is that odor processing through evolution has diverged so much from rodents that
there is no longer molecular specificity to glomerular targets; axons entering any given
glomerulus are no longer from OSNs that express the same OR. With mixed input, all
hypotheses about glomeruli acting as functional units, while still likely in rodents, would
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no longer be possible in humans. For example it would be impossible for a glomerulus to
enhance the signal-to-noise ratio if the input it was receiving was not homogeneous. In
this case it would certainly be necessary for sensory integration and odor processing to
take place at higher centers, and it certainly implies a loss in efficiency, which would also
explain humans’ decreased capacity for odor detection and discrimination.
So which of these explanations is correct? Immunohistochemical staining with
antibodies to specific ORs would in fact discriminate between many of these hypotheses.
As part of this study individual mOR antibodies were used to attempt to answer this
question, however the staining was not successful in that it did not identify any glomeruli
in the OB. It is likely that the antibodies, which are specific to mouse OBs, were not
specific enough to recognize the human OR proteins, or else the staining was localized in
glomeruli that weren’t represented on any of the slices examined. If a specific OR
antibody was developed that successfully stained glomeruli, the results would be
extremely informative. Large clusters of fluorescent glomeruli would indicate the
fragmentation of glomerular spheres into smaller units. Many glomeruli stained
throughout the bulb would indicate that there are more than two potential glomerular
targets per OR. Finally, staining of only a part of a glomerulus would indicate a loss of
molecularly specific glomerular input.

High variability in the number of glomeruli indicates that there are many factors
that can affect the organization of the OB.
In addition to the high number of glomeruli counted in each OB, another mystery
is the extreme variability in the number of glomeruli between different specimens,
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ranging from 2975 to 9325. This is not seen in rodents, in which there is a stereotypical
odor map including consistent numbers of glomeruli with specific localizations within the
OB. What potential factors could be influencing the number of glomeruli? Glomeruli are
composed of synaptic units between OSNs and PG cells, both of which are regenerated
throughout life, as well as projection neurons, the mitral and tufted cells, which are stable
and not regenerated. The sensory input comes in through the OSNs, without which the
glomeruli would not exist. Therefore, any significant loss of OSNs might disrupt the
synapses and result in a loss of glomeruli.
OSNs have their cell bodies in the olfactory epithelium (OE) in the back of the
nose. This location in the nose is efficient for detecting odors, however for the same
reason it is a sensitive area of tissue that is environmentally exposed to many pathogens
and toxins that are inhaled with the odorants. While most people experience temporary
olfactory dysfunction with minor upper respiratory infections, this is mostly due to the
congestion in the nasal passages that is obstructive to sniffing, and normal olfactory
function returns as soon as nasal congestion clears. However, people with more
significant sinus infections do experience post-infectious parosmia (94), likely related to
a disruption OSN integrity and normal OSN replication. In addition, patients who
undergo chemotherapy or radiation therapy to the head or neck region also commonly
experience parosmia, also likely due to the disruption of OSN replication. It is even
possible in these cases that replication of PG cell precursors is affected as well, which
might affect central processing of smell, adding another source of disturbance to
olfactory processing in these patients.
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Based on these lines of clinical evidence, it is appears that disruption of OSNs
leads to symptomatic variation in olfaction, however there is limited anatomical evidence
of how these changes are manifest in the human OB. There is MRI imaging evidence
that patients with post-traumatic and post-infectious olfactory dysfunction have smaller
OB volumes (79, 94) than controls. While there was no significant relationship between
OB size and number of glomeruli our study, this was one of the relationships in which
there was a positive trend, suggesting that with larger power to the study this relationship
may become significant. At the molecular and cellular level, a single previous study
attempted to look at the affect of cancer treatment, including chemotherapy and radiation
therapy of the head and neck, on OSN regeneration and number of glomeruli in the
human OB (95) in post-mortem donors. They noticed qualitatively less regeneration
based on GAP43 staining compared with controls, but did not note differences in
glomerular numbers. However, this evaluation of glomeruli was also qualitative, based
on a rating scale, using cellular staining to identify the gloerular structures. As
demonstrated earlier, qualitative evaluations of glomeruli, especially when based on PG
cell distribution, are unreliable predictors of actual glomerular quantifications.
Interestingly, the donor with the fewest number of glomeruli in our study was a
patient who had acute myelogenous leukemia who had undergone chemotherapy. From
the limited medical history that was available, it is unclear at what time point relative to
death he underwent this regimen. It is also unclear whether he had symptomatic
olfactory dysfunction. None of the donors had reported olfactory dysfunction, however
several studies documented that olfactory function is rarely addressed in medical practice,
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and in fact most patients with olfactory dysfunction are unaware of their condition (89,
96).
So what potential variations could be playing a role in the differences between
glomerular numbers for the other OBs evaluated in this study? Based on the small
number of OB specimens counted, there was no statistical significance between the
numbers of glomeruli and gender of the donor, nor was there a correlation between
number of glomeruli and age; however age was one of the comparisons that demonstrated
a trend that could potentially be significant with greater power to the study. It does make
logical sense that the olfactory system of an elderly person would be more likely to have
accumulated a lifetime of infectious and toxic exposures. Age, therefore, can be seen as
an indirect measure of these variables, which have been described earlier to likely play a
role in OSN integrity and regeneration, and possibly affect the number of glomeruli in the
OB. None of the available medical history for the OB donors provided meaningful
information regarding potential sources of OSN dysfunction that could lead to changes in
the numbers of glomeruli through this predicted mechanism. However, it is likely that
potentially relevant aspects of these patients’ clinical histories were either unrecognized
or unreported, so their absence certainly does not oppose this explanation. The best way
to explore this idea further would be to select OBs for evaluation from post-mortem
donors who had documented olfactory dysfunction due to trauma, infection, or chemical
exposures, as well as the OBs from normal controls with actual documentation of normal
olfactory function, and to compare these groups with relation to glomerular number and
overall OB organization.
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Finally, as an attempt to study “normal” human OB architecture, only OBs that
were from donors without neurodegenerative disorders were evaluated to prevent
obscuring of the normal and cellular and synaptic organization. There are documented
changes in OB architecture from patients with neurodegenerative disease, and in fact
most of the current studies of OB organization are currently focused around clinical
interests in these diseases, including most prominently Alzheimer’s disease (AD) and
Parkinson’s disease (PD). In both AD and more prominently in PD, olfactory
dysfunction is one of the earliest symptoms (97-100), and some have even proposed to
use olfactory testing to screen for these diseases in susceptible patient groups before
symptomatic onset (101). In AD, neurofibrillary tangles and senile plaques are found in
100% of the OBs of patients during post-mortem analysis (91), while in PD Lewy bodies
are also found in 100% of patients OBs (102). An interesting correlation would be to
evaluate the OBs from donors with known AD and PD to see how the architectural
changes affiliated with these diseases processes affect measures of olfactory processing
evaluated in this study.

So is there histologic evidence to explain a relatively inferior olfactory system?

There are several measures used to describe the acuity of the olfactory system.
One is odor threshold, or detection, another is odor identification, and the third is odor
discrimination. Based on genomic mining studies, it is already known that humans have
only about one-third the number of OR genes as compared to mice. With fewer ORs, it is
likely that humans are not able to recognize as many molecular odorants as mice and
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other mammalian species, decreasing our ability to identify odors. In addition, weaker
odorant binding to the ORs that are expressed, as well as binding of individual odorants
to fewer numbers of ORs, could result both in higher odor thresholds as well as poorer
odor discrimination. Therefore, simply looking at the genetics, humans already have a
basis for olfactory inferiority in all measures.

Within the central nervous system, odor identification occurs in the olfactory
cortex; however in order to correctly identify an odor, the sensory information must be
properly integrated within the OB before entering the LOT. In addition, both odor
threshold and odor discrimination are dependent upon local circuits within the OB. All
of these processes require coordination of input from the central nervous system, sensory
input from OSNs, as well as local circuit feedback and regulation through the PG cells
and granule cells. Therefore, disruption of the cellular and synaptic organization in the
OB would also detract from the human’s ability to detect, discriminate, and identify
odors. While this study was able to confirm many principles of local odor processing in
the OB, it identified several differences between humans and rodents at this level that
may in fact support the idea that central processing is in fact less efficient, differences
therefore that might begin to explain our poor sense of olfaction. Most importantly,
through simple quantification of glomeruli, this study raises interesting and essential
questions related to one of these most fundamental concepts of organization in the OB,
the idea of homotypic axon convergence and molecular specificity in glomeruli. In
conclusion, this study is only a brief and initial step in analyzing the organization of the
human OB, however several simple further experiments are proposed that may be able to
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answer some of these important questions.

77
REFERENCES

1. Hildebrand JG, Shepherd GM. Mechanisms of olfactory discrimination:
converging evidence for common principles across phyla. Annu Rev Neurosci
1997; 20:595-631.
2. Eisthen HL. Why are olfactory systems of different animals so similar? Brain
Behav Evol 2002; 59(5-6):273-293.
3. Ache BW, Young JM. Olfaction: diverse species, conserved principles. Neuron
2005; 48(3):417-430.
4. Conte C, Ebeling M, Marcuz A, Nef P, Andres-Barquin PJ. Evolutionary
relationships of the Tas2r receptor gene families in mouse and human. Physiol
Genomics 2003; 14(1):73-82.
5. Zhang X, Firestein S. The olfactory receptor gene superfamily of the mouse. Nat
Neurosci 2002; 5(2):124-133.
6. Zhang L, Ma B, Wang L, Xu Y. Greedy method for inferring tandem duplication
history. Bioinformatics 2003; 19(12):1497-1504.
7. Godfrey PA, Malnic B, Buck LB. The mouse olfactory receptor gene family. Proc
Natl Acad Sci U S A 2004; 101(7):2156-2161.
8. Buck L, Axel R. A novel multigene family may encode odorant receptors: a
molecular basis for odor recognition. Cell 1991; 65(1):175-187.
9. Pilpel Y, Lancet D. The variable and conserved interfaces of modeled olfactory
receptor proteins. Protein Sci 1999; 8(5):969-977.
10. Imai T, Suzuki M, Sakano H. Odorant receptor-derived cAMP signals direct
axonal targeting. Science 2006; 314(5799):657-661.
11. Mombaerts P. Molecular biology of odorant receptors in vertebrates. Annu Rev
Neurosci 1999; 22:487-509.

78
12. Mombaerts P. Seven-transmembrane proteins as odorant and chemosensory
receptors. Science 1999; 286(5440):707-711.
13. Glusman G, Bahar A, Sharon D, Pilpel Y, White J, Lancet D. The olfactory
receptor gene superfamily: data mining, classification, and nomenclature. Mamm
Genome 2000; 11(11):1016-1023.
14. Buck LB. The olfactory multigene family. Curr Opin Genet Dev 1992; 2(3):467473.
15. Young JM, Trask BJ. The sense of smell: genomics of vertebrate odorant
receptors. Hum Mol Genet 2002; 11(10):1153-1160.
16. Brosius J. Many G-protein-coupled receptors are encoded by retrogenes. Trends
Genet 1999; 15(8):304-305.
17. Gentles AJ, Karlin S. Why are human G-protein-coupled receptors predominantly
intronless? Trends Genet 1999; 15(2):47-49.
18. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG et al. The
sequence of the human genome. Science 2001; 291(5507):1304-1351.
19. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J et al. Initial
sequencing and analysis of the human genome. Nature 2001; 409(6822):860-921.
20. Glusman G, Yanai I, Rubin I, Lancet D. The complete human olfactory
subgenome. Genome Res 2001; 11(5):685-702.
21. Fuchs T, Glusman G, Horn-Saban S, Lancet D, Pilpel Y. The human olfactory
subgenome: from sequence to structure and evolution. Hum Genet 2001;
108(1):1-13.
22. Zozulya S, Echeverri F, Nguyen T. The human olfactory receptor repertoire.
Genome Biol 2001; 2(6):RESEARCH0018.
23. Quignon P, Giraud M, Rimbault M, Lavigne P, Tacher S, Morin E et al. The dog
and rat olfactory receptor repertoires. Genome Biol 2005; 6(10):R83.

79
24. Lapidot M, Pilpel Y, Gilad Y, Falcovitz A, Sharon D, Haaf T et al. Mouse-human
orthology relationships in an olfactory receptor gene cluster. Genomics 2001;
71(3):296-306.
25. Bulger M, Bender MA, van Doorninck JH, Wertman B, Farrell CM, Felsenfeld G
et al. Comparative structural and functional analysis of the olfactory receptor
genes flanking the human and mouse beta-globin gene clusters. Proc Natl Acad
Sci U S A 2000; 97(26):14560-14565.
26. Lane RP, Cutforth T, Young J, Athanasiou M, Friedman C, Rowen L et al.
Genomic analysis of orthologous mouse and human olfactory receptor loci. Proc
Natl Acad Sci U S A 2001; 98(13):7390-7395.
27. Younger RM, Amadou C, Bethel G, Ehlers A, Lindahl KF, Forbes S et al.
Characterization of clustered MHC-linked olfactory receptor genes in human and
mouse. Genome Res 2001; 11(4):519-530.
28. Dehal P, Predki P, Olsen AS, Kobayashi A, Folta P, Lucas S et al. Human
chromosome 19 and related regions in mouse: conservative and lineage-specific
evolution. Science 2001; 293(5527):104-111.
29. Young JM, Friedman C, Williams EM, Ross JA, Tonnes-Priddy L, Trask BJ.
Different evolutionary processes shaped the mouse and human olfactory receptor
gene families. Hum Mol Genet 2002; 11(5):535-546.
30. Malnic B, Hirono J, Sato T, Buck LB. Combinatorial receptor codes for odors.
Cell 1999; 96(5):713-723.
31. Touhara K. Functional cloning and reconstitution of vertebrate odorant receptors.
Life Sci 2001; 68(19-20):2199-2206.
32. Kajiya K, Inaki K, Tanaka M, Haga T, Kataoka H, Touhara K. Molecular bases of
odor discrimination: Reconstitution of olfactory receptors that recognize
overlapping sets of odorants. J Neurosci 2001; 21(16):6018-6025.
33. Chess A, Simon I, Cedar H, Axel R. Allelic inactivation regulates olfactory
receptor gene expression. Cell 1994; 78(5):823-834.

80
34. Mombaerts P, Wang F, Dulac C, Chao SK, Nemes A, Mendelsohn M et al.
Visualizing an olfactory sensory map. Cell 1996; 87(4):675-686.
35. Strotmann J, Conzelmann S, Beck A, Feinstein P, Breer H, Mombaerts P. Local
permutations in the glomerular array of the mouse olfactory bulb. J Neurosci
2000; 20(18):6927-6938.
36. Ressler KJ, Sullivan SL, Buck LB. A zonal organization of odorant receptor gene
expression in the olfactory epithelium. Cell 1993; 73(3):597-609.
37. Vassar R, Ngai J, Axel R. Spatial segregation of odorant receptor expression in
the mammalian olfactory epithelium. Cell 1993; 74(2):309-318.
38. Sullivan SL, Adamson MC, Ressler KJ, Kozak CA, Buck LB. The chromosomal
distribution of mouse odorant receptor genes. Proc Natl Acad Sci U S A 1996;
93(2):884-888.
39. Cajal, R.S. (1911) Histologie du Systeme Neurneux de l’Hommes et des
Vetebres. Tome 2. Institut Ramon y Cajal, Madrid.

40.

Shepherd, G.M., Chen, W.R., Greer, C.A. (2004) in The Synaptic Organization
of the Brain, ed. Shepherd, G.G. (Oxford Univ. Press, New York), pp. 165-216.

41. Treloar H, Walters E, Margolis F, Key B. Olfactory glomeruli are innervated by
more than one distinct subset of primary sensory olfactory neurons in mice. J
Comp Neurol 1996; 367(4):550-562.
42. Mori K, Nagao H, Yoshihara Y. The olfactory bulb: coding and processing of
odor molecule information. Science 1999; 286(5440):711-715.
43. Allison AC. The structure of the olfactory bulb and its relationship to the
olfactory pathways in the rabbit and the rat. J Comp Neurol 1953; 98(2):309-353.
44. Shepherd GM. The human sense of smell: are we better than we think? PLoS Biol
2004; 2(5):E146.

81
45. Klenoff JR, Greer CA. Postnatal development of olfactory receptor cell axonal
arbors. J Comp Neurol 1998; 390(2):256-267.
46. Vassar R, Chao SK, Sitcheran R, Nunez JM, Vosshall LB, Axel R. Topographic
organization of sensory projections to the olfactory bulb. Cell 1994; 79(6):981991.
47. Ressler KJ, Sullivan SL, Buck LB. Information coding in the olfactory system:
evidence for a stereotyped and highly organized epitope map in the olfactory
bulb. Cell 1994; 79(7):1245-1255.
48. Ressler KJ, Sullivan SL, Buck LB. A molecular dissection of spatial patterning in
the olfactory system. Curr Opin Neurobiol 1994; 4(4):588-596.
49. Jourdan F. Spatial dimension in olfactory coding: a representation of the 2deoxyglucose patterns of glomerular labeling in the olfactory bulb. Brain Res
1982; 240(2):341-344.
50. Sharp FR, Kauer JS, Shepherd GM. Local sites of activity-related glucose
metabolism in rat olfactory bulb during olfactory stimulation. Brain Res 1975;
98(3):596-600.
51. Stewart WB, Kauer JS, Shepherd GM. Functional organization of rat olfactory
bulb analysed by the 2-deoxyglucose method. J Comp Neurol 1979; 185(4):715734.
52. Keller A, Yagodin S, Aroniadou-Anderjaska V, Zimmer LA, Ennis M, Sheppard
NF, Jr. et al. Functional organization of rat olfactory bulb glomeruli revealed by
optical imaging. J Neurosci 1998; 18(7):2602-2612.
53. Spors H, Grinvald A. Spatio-temporal dynamics of odor representations in the
mammalian olfactory bulb. Neuron 2002; 34(2):301-315.
54. Katoh K, Koshimoto H, Tani A, Mori K. Coding of odor molecules by
mitral/tufted cells in rabbit olfactory bulb. II. Aromatic compounds. J
Neurophysiol 1993; 70(5):2161-2175.

82
55. Wang F, Nemes A, Mendelsohn M, Axel R. Odorant receptors govern the
formation of a precise topographic map. Cell 1998; 93(1):47-60.
56. Bozza T, Feinstein P, Zheng C, Mombaerts P. Odorant receptor expression
defines functional units in the mouse olfactory system. J Neurosci 2002;
22(8):3033-3043.
57. Treloar HB, Feinstein P, Mombaerts P, Greer CA. Specificity of glomerular
targeting by olfactory sensory axons. J Neurosci 2002; 22(7):2469-2477.
58. Royet JP, Souchier C, Jourdan F, Ploye H. Morphometric study of the glomerular
population in the mouse olfactory bulb: numerical density and size distribution
along the rostrocaudal axis. J Comp Neurol 1988; 270(4):559-568.
59. Meisami E. A New Morphometric Method to Estimate the Total Number of
Glomeruli in the Olfactory-Bulb. Chemical Senses 1990; 15(4):407-418.
60. Wachowiak M, Cohen LB. Representation of odorants by receptor neuron input to
the mouse olfactory bulb. Neuron 2001; 32(4):723-735.
61. Uchida N, Mainen ZF. Speed and accuracy of olfactory discrimination in the rat.
Nat Neurosci 2003; 6(11):1224-1229.
62. Xu F, Liu N, Kida I, Rothman DL, Hyder F, Shepherd GM. Odor maps of
aldehydes and esters revealed by functional MRI in the glomerular layer of the
mouse olfactory bulb. Proc Natl Acad Sci U S A 2003; 100(19):11029-11034.
63. Takahashi YK, Kurosaki M, Hirono S, Mori K. Topographic representation of
odorant molecular features in the rat olfactory bulb. J Neurophysiol 2004;
92(4):2413-2427.
64. Chen WR, Shepherd GM. The olfactory glomerulus: a cortical module with
specific functions. J Neurocytol 2005; 34(3-5):353-360.
65. Schnell SA, Staines WA, Wessendorf MW. Reduction of lipofuscin-like
autofluorescence in fluorescently labeled tissue. J Histochem Cytochem 1999;
47(6):719-730.

83
66. Kim H, Greer CA. The emergence of compartmental organization in olfactory
bulb glomeruli during postnatal development. J Comp Neurol 2000; 422(2):297311.
67. Kosaka K, Toida K, Margolis FL, Kosaka T. Chemically defined neuron groups
and their subpopulations in the glomerular layer of the rat main olfactory bulb--II.
Prominent differences in the intraglomerular dendritic arborization and their
relationship to olfactory nerve terminals. Neuroscience 1997; 76(3):775-786.
68. Kosaka K, Toida K, Aika Y, Kosaka T. How simple is the organization of the
olfactory glomerulus?: the heterogeneity of so-called periglomerular cells.
Neurosci Res 1998; 30(2):101-110.
69. Kasowski HJ, Kim H, Greer CA. Compartmental organization of the olfactory
bulb glomerulus. J Comp Neurol 1999; 407(2):261-274.
70. Whitman MC, Greer CA. Heterogeneity among adult generated olfactory bulb
periglomerular cells. Dev Neurobio 2007; In press.
71. Ribak CE, Vaughn JE, Saito K, Barber R, Roberts E. Glutamate decarboxylase
localization in neurons of the olfactory bulb. Brain Res 1977; 126(1):1-18.
72. Mugnaini E, Wouterlood FG, Dahl AL, Oertel WH. Immunocytochemical
identification of GABAergic neurons in the main olfactory bulb of the rat. Arch
Ital Biol 1984; 122(2):83-113.
73. Kosaka T, Kosaka K, Heizmann CW, Nagatsu I, Wu JY, Yanaihara N et al. An
aspect of the organization of the GABAergic system in the rat main olfactory
bulb: laminar distribution of immunohistochemically defined subpopulations of
GABAergic neurons. Brain Res 1987; 411(2):373-378.
74. Kosaka K, Hama K, Nagatsu I, Wu JY, Kosaka T. Possible coexistence of amino
acid (gamma-aminobutyric acid), amine (dopamine) and peptide (substance P);
neurons containing immunoreactivities for glutamic acid decarboxylase, tyrosine
hydroxylase and substance P in the hamster main olfactory bulb. Exp Brain Res
1988; 71(3):633-642.
75. Halasz N, Hokfelt T, Ljungdahl A, Johansson O, Goldstein M. Dopamine neurons
in the olfactory bulb. Adv Biochem Psychopharmacol 1977; 16:169-177.

84
76. Davis BJ, Macrides F. Tyrosine-Hydroxylase Immunoreactive Neurons and
Fibers in the Olfactory System of the Hamster. Journal of Comparative Neurology
1983; 214(4):427-440.
77. Jacobowitz DM, Winsky L. Immunocytochemical localization of calretinin in the
forebrain of the rat. J Comp Neurol 1991; 304(2):198-218.
78. Rogers JH. Immunohistochemical markers in rat brain: colocalization of calretinin
and calbindin-D28k with tyrosine hydroxylase. Brain Res 1992; 587(2):203-210.
79. Rombaux P, Mouraux A, Bertrand B, Nicolas G, Duprez T, Hummel T. Olfactory
function and olfactory bulb volume in patients with postinfectious olfactory loss.
Laryngoscope 2006; 116(3):436-439.
80. Meisami E, Mikhail L, Baim D, Bhatnagar KP. Human olfactory bulb: aging of
glomeruli and mitral cells and a search for the accessory olfactory bulb. Ann N Y
Acad Sci 1998; 855:708-715.
81. Nakashima T, Kimmelman CP, Snow JB, Jr. Immunohistopathology of human
olfactory epithelium, nerve and bulb. Laryngoscope 1985; 95(4):391-396.
82. Ohm TG, Braak E, Probst A, Weindl A. Neuropeptide Y-like immunoreactive
neurons in the human olfactory bulb. Brain Res 1988; 451(1-2):295-300.
83. Ohm TG, Muller H, Ulfig N, Braak E. Glutamic-acid-decarboxylase-and
parvalbumin-like-immunoreactive structures in the olfactory bulb of the human
adult. J Comp Neurol 1990; 291(1):1-8.
84. Ohm TG, Muller H, Braak E. Calbindin-D-28k-like immunoreactive structures in
the olfactory bulb and anterior olfactory nucleus of the human adult: distribution
and cell typology--partial complementarity with parvalbumin. Neuroscience 1991;
42(3):823-840.
85. Smith RL, Baker H, Kolstad K, Spencer DD, Greer CA. Localization of tyrosine
hydroxylase and olfactory marker protein immunoreactivities in the human and
macaque olfactory bulb. Brain Res 1991; 548(1-2):140-148.

85
86. Smith RL, Baker H, Greer CA. Immunohistochemical analyses of the human
olfactory bulb. J Comp Neurol 1993; 333(4):519-530.
87. Bedard A, Parent A. Evidence of newly generated neurons in the human olfactory
bulb. Brain Res Dev Brain Res 2004; 151(1-2):159-168.
88. Doty RL, Shaman P, Applebaum SL, Giberson R, Siksorski L, Rosenberg L.
Smell identification ability: changes with age. Science 1984; 226(4681):14411443.
89. Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM.
Prevalence of olfactory impairment in older adults. JAMA 2002; 288(18):23072312.
90. Hoogland PV, van den BR, Huisman E. Misrouted olfactory fibres and ectopic
olfactory glomeruli in normal humans and in Parkinson and Alzheimer patients.
Neuropathol Appl Neurobiol 2003; 29(3):303-311.
91. Kovacs T, Cairns NJ, Lantos PL. beta-amyloid deposition and neurofibrillary
tangle formation in the olfactory bulb in ageing and Alzheimer's disease.
Neuropathol Appl Neurobiol 1999; 25(6):481-491.
92. Linardopoulou E, Mefford HC, Nguyen O, Friedman C, van den EG, Farwell DG
et al. Transcriptional activity of multiple copies of a subtelomerically located
olfactory receptor gene that is polymorphic in number and location. Hum Mol
Genet 2001; 10(21):2373-2383.
93. Feinstein P, Mombaerts P. A contextual model for axonal sorting into glomeruli
in the mouse olfactory system. Cell 2004; 117(6):817-831.
94. Mueller A, Rodewald A, Reden J, Gerber J, von Kummer R, Hummel T. Reduced
olfactory bulb volume in post-traumatic and post-infectious olfactory dysfunction.
Neuroreport 2005; 16(5):475-478.
95. Struble RG, Ghobrial M. Cancer treatment and growth cone-associated protein in
human olfactory bulb glomeruli. Arch Otolaryngol Head Neck Surg 1998;
124(8):867-870.

86
96. Doty RL, Reyes PF, Gregor T. Presence of both odor identification and detection
deficits in Alzheimer's disease. Brain Res Bull 1987; 18(5):597-600.
97. Serby M, Larson P, Kalkstein D. The nature and course of olfactory deficits in
Alzheimer's disease. Am J Psychiatry 1991; 148(3):357-360.
98. Graves AB, Bowen JD, Rajaram L, McCormick WC, McCurry SM, Schellenberg
GD et al. Impaired olfaction as a marker for cognitive decline: interaction with
apolipoprotein E epsilon4 status. Neurology 1999; 53(7):1480-1487.
99. Ansari KA, Johnson A. Olfactory function in patients with Parkinson's disease. J
Chronic Dis 1975; 28(9):493-497.
100. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general
deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology
1988; 38(8):1237-1244.
101. Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of
Parkinson's disease: development of optimal discrimination criteria.
Neurodegeneration 1995; 4(1):93-97.
102. Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's
disease. J Neurol Neurosurg Psychiatry 1997; 62(5):436-446.

